Heterozygous expression of a Kcnt1 gain-of-function variant has differential effects on somatostatin- and parvalbumin-expressing cortical GABAergic neurons

  1. Amy N Shore
  2. Keyong Li
  3. Mona Safari
  4. Alshaima'a M Qunies
  5. Brittany D Spitznagel
  6. C David Weaver
  7. Kyle Emmitte
  8. Wayne Frankel
  9. Matthew C Weston  Is a corresponding author
  1. Fralin Biomedical Research Institute at Virginia Tech Carilion, Center for Neurobiology Research, United States
  2. Department of Neurological Sciences, University of Vermont, United States
  3. Translational Biology, Medicine, and Health Graduate Program, Fralin Biomedical Research Institute at Virginia Tech Carilion, United States
  4. Department of Pharmaceutical Sciences, UNT System College of Pharmacy, University of North Texas Health Science Center, United States
  5. School of Biomedical Sciences, University of North Texas Health Science Center, United States
  6. Department of Pharmacology, Vanderbilt University, United States
  7. Vanderbilt Institute of Chemical Biology, Vanderbilt University, United States
  8. Department of Chemistry, Vanderbilt University, United States
  9. Institute for Genomic Medicine, Columbia University, United States
  10. Department of Neurology, Columbia University, United States
  11. School of Neuroscience, Virginia Tech, United States

eLife assessment

Shore et al. report the important effects of a heterozygous mutation in the KCNT1 potassium channel on ion currents and firing behavior of excitatory and inhibitory neurons in the cortex of KCNT1-Y777H mice. The authors provide solid evidence of physiological differences between this heterozygous mutation and their previous work with homozygotes. The reviewers appreciated the inclusion of recordings in ex vivo slices and dissociated cortical neurons, as well as the additional evidence showing an increase in persistent sodium currents in parvalbumin-positive interneurons in heterozygotes.

https://doi.org/10.7554/eLife.92915.4.sa0

Abstract

More than 20 recurrent missense gain-of-function (GOF) mutations have been identified in the sodium-activated potassium (KNa) channel gene KCNT1 in patients with severe developmental and epileptic encephalopathies (DEEs), most of which are resistant to current therapies. Defining the neuron types most vulnerable to KCNT1 GOF will advance our understanding of disease mechanisms and provide refined targets for precision therapy efforts. Here, we assessed the effects of heterozygous expression of a Kcnt1 GOF variant (Kcnt1Y777H) on KNa currents and neuronal physiology among cortical glutamatergic and GABAergic neurons in mice, including those expressing vasoactive intestinal polypeptide (VIP), somatostatin (SST), and parvalbumin (PV), to identify and model the pathogenic mechanisms of autosomal dominant KCNT1 GOF variants in DEEs. Although the Kcnt1Y777H variant had no effects on glutamatergic or VIP neuron function, it increased subthreshold KNa currents in both SST and PV neurons but with opposite effects on neuronal output; SST neurons became hypoexcitable with a higher rheobase current and lower action potential (AP) firing frequency, whereas PV neurons became hyperexcitable with a lower rheobase current and higher AP firing frequency. Further neurophysiological and computational modeling experiments showed that the differential effects of the Kcnt1Y777H variant on SST and PV neurons are not likely due to inherent differences in these neuron types, but to an increased persistent sodium current in PV, but not SST, neurons. The Kcnt1Y777H variant also increased excitatory input onto, and chemical and electrical synaptic connectivity between, SST neurons. Together, these data suggest differential pathogenic mechanisms, both direct and compensatory, contribute to disease phenotypes, and provide a salient example of how a pathogenic ion channel variant can cause opposite functional effects in closely related neuron subtypes due to interactions with other ionic conductances.

Introduction

Heterozygous missense variants have been identified in the sodium-gated potassium channel gene KCNT1 in more than 200 individuals exhibiting a wide spectrum of developmental and epileptic encephalopathies (DEEs), with the majority being classified as either epilepsy of infancy with migrating focal seizures or autosomal dominant or sporadic sleep-related hypermotor epilepsy (Barcia et al., 2012; Bonardi et al., 2021; Heron et al., 2012). Each of these epilepsy syndromes result in early-onset, frequent seizures that are largely pharmacoresistant and often accompanied by a range of cognitive, psychiatric, and motor impairments. Thus, there is a critical need for a better understanding of how heterozygous expression of these KCNT1 variants in the developing brain alters neuronal physiology and network behavior to lead to such devastating neurodevelopmental disorders.

KCNT1 encodes a tetrameric potassium channel that is widely expressed in both glutamatergic and GABAergic neurons of the brain, particularly those of the cerebellum, striatum, thalamus, hippocampus, and cortex (Berg et al., 2007; Bhattacharjee et al., 2002; Gertler et al., 2022; Rizzi et al., 2016). Although its precise role in normal physiology is not well understood, at least in some neuronal types, KCNT1 is activated by a persistent inward sodium leak (NaP) current at rest, where it has a proposed role in fine tuning neuronal excitability by countering the effects of the NaP current across subthreshold voltages (Budelli et al., 2009; Hage and Salkoff, 2012). Consistent with this role, loss-of-function (LOF) studies using mouse models lacking KCNT1, and the associated sodium-activated potassium (KNa) current, have shown enhanced action potential (AP) firing across multiple neuron types (Evely et al., 2017; Liu et al., 2022; Lu et al., 2015; Martinez-Espinosa et al., 2015; Reijntjes et al., 2019; Zhang et al., 2022). Characterizations of pathogenic DEE-associated KCNT1 variants in heterologous cells found that nearly all cause gain-of-function (GOF) effects on the channel, increasing the associated KNa current (Hinckley et al., 2023; Kim et al., 2014; McTague et al., 2018; Milligan et al., 2014; Tang et al., 2016). Based on LOF studies, this would be expected to reduce neuronal excitability; however, it is difficult to predict the effects of these GOF variants on AP generation in neurons, particularly among neuronal subtypes, a priori.

To address this knowledge gap, we previously generated and characterized a mouse model expressing a human ADNFLE-associated KCNT1 GOF variant (Y796H or Y777H in mice) (Shore et al., 2020). Although heterozygous expression of the KCNT1-Y796H variant is sufficient to cause severe childhood epilepsy in humans, we only observed rare behavioral seizures in heterozygous Kcnt1Y777H mice see Discussion (Shore et al., 2020); however, we identified hyperexcitable, hypersynchronous cortical networks and frequent, early-onset seizures in homozygous Kcnt1Y777H mice. As a potential underlying mechanism of these network alterations, we demonstrated that homozygous Kcnt1Y777H expression increases subthreshold KNa currents and reduces excitability in GABAergic neuron populations, particularly in those classified as non-fast spiking (NFS), but it does not alter glutamatergic neuron excitability. We further observed evidence of homeostatic compensation and network remodeling downstream of KNa current increases during development, including increased excitatory input onto glutamatergic and NFS GABAergic neurons, and enhanced homotypic synaptic connectivity. Although these findings provide a strong mechanistic basis for understanding how KCNT1 GOF disrupts neuronal physiology and network behavior to lead to seizure disorders, key issues remain unresolved. First, considering the heterozygous nature of KCNT1 GOF variants in the overwhelming majority of KCNT1-related DEE patients, it is crucial to determine whether heterozygous Kcnt1Y777H expression results in similar neuronal impairments and network alterations to those with homozygous expression. Second, more recent studies, using both in silico modeling and additional construct-valid mouse models, have similarly identified impairments in GABAergic neuron excitability downstream of KCNT1 GOF (Gertler et al., 2022; Kuchenbuch et al., 2021; Wu et al., 2024), indicating impaired inhibition as a shared pathogenic mechanism in KCNT1-related DEEs; however, precisely which GABAergic subtypes are most impacted, and how, remains unknown.

Here, we assessed the effects of heterozygous Kcnt1Y777H expression on KNa currents and neuronal physiology among cortical glutamatergic and GABAergic neurons, including those expressing vasoactive intestinal polypeptide (VIP), somatostatin (SST), and parvalbumin (PV). Initial assessments of cortical neuron populations with heterozygous Kcnt1Y777H expression showed strikingly similar effects on KNa currents and AP generation to those with homozygous expression, although not surprisingly, these effects were lesser in magnitude. Across all cortical neuron types examined, the heterozygous Kcnt1Y777H variant caused a range of effects on neuronal excitability and AP generation, from no change (glutamatergic and VIP GABAergic) to decreased excitability (SST GABAergic) to increased excitability (PV GABAergic). Neuron types that showed no change had KNa currents that were only significantly increased at suprathreshold voltages and exhibited a steeper voltage dependence of activation. Interestingly, both SST and PV neurons showed similar increases in KNa currents across subthreshold voltages, however, only PV neurons had additional increases in the persistent Na+ current, which modeling experiments indicated was sufficient to overcome the effects of KCNT1 GOF and cause an overall increase in AP generation. SST neurons also showed an increase in excitatory input, and in homotypic electrical and chemical coupling. Taken together, these data provide further evidence of the enhanced vulnerability of GABAergic neurons, particularly those expressing SST and PV, to KCNT1 GOF. Moreover, these data show that heterozygous expression of a single KCNT1 GOF variant can result in a complex array of neuron-type-dependent effects, both direct and indirect, each potential contributor to the neural circuit pathology underlying KCNT1-related DEEs.

Results

Heterozygous Kcnt1Y777H expression alters the shape and frequency of APs in NFS GABAergic neurons

We previously identified frequent, early-onset seizures in mice with homozygous expression of the Kcnt1 GOF variant Y777H (hereafter referred to as YH-HOM), and as a potential underlying pathological mechanism, we demonstrated that homozygous Kcnt1Y777H expression drastically impairs AP shape and generation in NFS GABAergic cortical neurons, with lesser effects on fast spiking (FS) GABAergic, and no significant effects on glutamatergic, cortical neurons (Shore et al., 2020). Considering that patients with KCNT1-associated epilepsy are predominantly heterozygous for KCNT1 GOF variants, it is crucial to determine whether heterozygous expression of these variants, which likely leads to the formation of heteromeric channels consisting of wildtype (WT) and mutant subunits, results in similar neuronal impairments. To assess neuron subtype-specific effects of heterozygous KCNT1 GOF on membrane properties and AP firing, we isolated and cultured cortical neurons from pups with heterozygous Kcnt1Y777H expression (hereafter referred to as YH-HET), and their WT littermates, at postnatal day 0 (P0). After infecting the cultured neurons with AAV-CaMKIIa-GFP to facilitate glutamatergic neuron identification, we performed whole-cell, current-clamp analysis between 13 and 17 days in vitro (DIV). Moreover, to compare to homozygous KCNT1 GOF effects observed previously, the recorded neurons were classified as glutamatergic, FS GABAergic, or NFS GABAergic, based on GFP expression, AP parameters, and evoked synaptic responses (see Methods).

Current-clamp recordings from YH-HET and WT glutamatergic neurons showed no significant differences in any membrane or AP shape property measured (Figure 1A1 and Supplementary file 1), similar to observations from the homozygous KCNT1 GOF studies. Accordingly, AP firing frequencies across increasing current steps in YH-HET glutamatergic neurons were not altered compared with those of WT (Figure 1B1). For FS GABAergic neurons, we previously showed that homozygous Kcnt1Y777H expression increases the rheobase—the minimal amount of current necessary to induce an AP—and reduces the AP firing frequency. Heterozygous Kcnt1Y777H expression did not alter the rheobase, or any other passive or active membrane property of FS GABAergic neurons (Figure 1A2 and Supplementary file 1). Although YH-HET FS GABAergic neurons appeared to fire fewer APs than their WT counterparts, particularly at higher current steps, this effect was not significant (Figure 1B2). Lastly, we previously showed that homozygous Kcnt1Y777H expression has the strongest effects in NFS GABAergic neurons, showing a decrease in input resistance, accompanied by an increase in rheobase and a reduction in AP firing frequency. YH-HOM NFS GABAergic neurons also have narrower AP half-widths and larger afterhyperpolarizations (AHPs) than those of WT. Although heterozygous Kcnt1Y777H expression in NFS GABAergic neurons did not cause a significant decrease in input resistance (WT: 171 ± 16; YH-HET: 146 ± 14, p = 0.19), it did increase the rheobase and reduce the AP firing frequency, particularly at lower current steps, relative to those of WT (Figure 1A3, B3). YH-HET NFS GABAergic neurons also had narrower APs, larger AHPs, and more depolarized AP thresholds than those of WT (Supplementary file 1). Together, these data demonstrate that the neurophysiological effects on cortical neurons with monoallelic expression of the Kcnt1Y777H variant, expressing channels with mutant and WT subunits, are similar to those with biallelic expression, expressing only mutant subunits, with both causing the strongest impairments in NFS GABAergic neurons.

Heterozygous Kcnt1Y777H expression alters action potential (AP) shape and generation in non-fast spiking (NFS) GABAergic neurons.

(A1–A3) On the left, representative responses to step currents are shown for glutamatergic, and fast spiking (FS) and NFS GABAergic, wildtype (WT) (black) and YH-HET (colors) neurons (top to bottom), illustrating the input resistance (in response to a hyperpolarizing step) and the rheobase (the first trace with an AP in response to a depolarizing step) for each neuron type. On the right, bar graphs show quantification and mean ± standard error of the mean (SEM) of the membrane properties and AP parameters for each neuron type for WT (gray) and YH-HET (colors) groups, with individual neuron measurements overlaid in scatter plots. The p-values are shown on each graph where p < 0.05. (B1–B3) Representative traces are shown at low, medium, and high current steps for glutamatergic, and FS and NFS GABAergic, WT (black) and YH-HET (colors) neurons (left to right). The line graphs below show the number of APs (mean ± SEM) per current injection step in WT (black) and YH-HET (colors) neurons. Statistical significance was tested using generalized linear mixed models, and p-values are shown on each graph where p < 0.05. Data from this figure are from 9 WT and 9 YH-HET littermate pups, with the following neuron sample sizes: glutamatergic WT (n=27) and YH-HET (n=30), FS GABAergic WT (n=27) and YH-HET (n=29), and NFS GABAergic WT (n=26) and YH-HET (n=22).

Figure 1—source data 1

File containing data used to generate the graphs in Figure 1.

https://cdn.elifesciences.org/articles/92915/elife-92915-fig1-data1-v1.xlsx

Heterozygous Kcnt1Y777H expression increases subthreshold KNa currents in NFS GABAergic neurons

Previously, we showed that homozygous Kcnt1Y777H expression in GABAergic cortical neurons increases the KNa current across subthreshold voltages, an effect that is particularly evident in NFS GABAergic neurons; conversely, in glutamatergic cortical neurons with homozygous expression of the same variant, increases in KNa currents are only apparent at depolarized voltages (>+30 mV) (Shore et al., 2020). To assess the effects of heterozygous Kcnt1Y777H expression on KCNT1 channel function, we measured the associated KNa current in each cortical neuron subtype. We recorded KNa currents by applying voltage steps to voltage-clamped neurons and comparing the delayed outward current before and after the addition of the voltage-gated sodium channel inhibitor tetrodotoxin (TTX) (Figure 2A13). As reported previously, there were KNa currents in all three WT neuron subtypes, beginning around −10 mV and increasing with depolarization (Figure 2A13), whereas at more negative potentials, the TTX-sensitive current was net inward (Figure 2C13) due to the counteracting persistent Na+ current.

Figure 2 with 1 supplement see all
Heterozygous Kcnt1Y777H expression increases subthreshold KNa currents in non-fast spiking (NFS) GABAergic neurons.

(A1–A3) Representative traces in control (top), 0.5 µM tetrodotoxin (TTX) (middle), and the difference current (bottom) calculated by subtracting the membrane current response to voltage steps (−80 to +50 mV) from a holding potential of −70 mV in TTX from the response in control external solution in glutamatergic, and fast spiking (FS) and NFS GABAergic, wildtype (WT) (black) and YH-HET (colors) neurons. To include all of the representative traces in the figures, and prevent overlap of the traces, the large inward sodium currents were removed from each set of traces using the masking tool in Adobe Illustrator. (B1–B3) Summary data show the KNa current (mean ± SEM) for each voltage step in glutamatergic, and FS and NFS GABAergic, WT (black and gray) and YH-HET (colors) neurons. The p-values are shown on each graph where p < 0.05, and the n values are the number of neurons recorded for each group. (C1–C3) Plots of the KNa current (mean ± SEM) for each voltage step from −80 to 0 mV in WT (black and gray) and YH-HET (colors) neurons to illustrate the values that are too small to be seen on the graphs in B1–B3. The shaded red area in C3 indicates the subthreshold voltage range with significantly higher KNa currents (red voltages along x-axis indicate steps where p < 0.05) in YH-HET relative to WT neurons. Statistical significance for IV plots was tested using generalized linear mixed models with genotype and voltage step as fixed effects followed by pairwise comparisons at each level.

Figure 2—source data 1

File containing data used to generate the graphs in Figure 2.

https://cdn.elifesciences.org/articles/92915/elife-92915-fig2-data1-v1.xlsx
Heterozygous Kcnt1Y777H expression does not alter synaptic connectivity or the excitation–inhibition balance.

(A1–A4) Evoked postsynaptic currents (PSCs) were recorded from neuron pairs glutamatergic (excitatory, E) and GABAergic (inhibitory, I) by stimulating the neuron type indicated on the left and recording the response in the neuron type indicated on the right (wildtype [WT], gray; YH-HET E, green; YH-HET I, red). Bar graphs below each recorded neuron pair schematic show summary data (mean ± SEM) of the connection probability (left graph; numbers on bars represent connected pair number/recorded pair number) and peak evoked PSC amplitude (right graph; dots represent individual evoked responses) between each motif. (B1) Bar graphs with overlaid individual neuron measurements and mean ± SEM show the spontaneous EPSC (sEPSC) or IPSC (sIPSC) frequency onto E neurons (WT, gray; YH-HET, green). (B2) Bar graphs with overlaid individual neuron measurements and mean ± SEM show the sEPSC or sIPSC frequency onto I neurons (WT, gray; YH-HET, red). (B3) Scatter plots show individual E/I ratio measurements onto E neurons (WT, gray; YH-HET, green) and I neurons (WT, gray; YH-HET, red). The p-values are shown on each graph where p < 0.05.

Figure 3—source data 1

File containing data used to generate the graphs in Figure 3.

https://cdn.elifesciences.org/articles/92915/elife-92915-fig3-data1-v1.xlsx

In glutamatergic and NFS GABAergic YH-HET neurons, the overall KNa current was increased relative to those of WT, as measured by a significant effect of genotype using a linear model (Figure 2B1, 3). Importantly, in each of these neuron subtypes, heterozygous Kcnt1Y777H expression increased KNa currents with distinct, voltage-dependent patterns that appeared strikingly similar to those reported with homozygous expression. For instance, we previously showed that, across negative potentials, YH-HOM and WT glutamatergic neuron KNa currents are indistinguishable, whereas at more positive potentials (>+30 mV), the Kcnt1Y777H variant causes significant increases in KNa currents. Similar voltage-dependent effects were observed in YH-HET glutamatergic neurons (Figure 2B1, C1), although pairwise comparisons showed that KNa current increases at positive potentials in the YH-HET glutamatergic neurons were not significant. Conversely, we previously demonstrated broad increases in KNa currents across negative potentials, with significant increases from −60 to +10 mV, in YH-HOM NFS GABAergic neurons compared with those of WT, with lesser effects across positive potentials. Similar voltage-dependent increases were observed in YH-HET NFS GABAergic neurons, with pairwise comparisons showing significant KNa current increases at −70, −60, −50, and −20 mV (Figure 2B3, C3). For both glutamatergic and NFS GABAergic neurons, the magnitudes of the KNa current increases in YH-HET neurons were intermediate to those of WT and YH-HOM neurons (Figure 2—figure supplement 1), demonstrating a gene dose-dependent effect of the Kcnt1Y777H variant on KNa current increases and validating a GOF effect of the heterozygous Kcnt1Y777H variant on channel function. Lastly, although previous studies showed that homozygous Kcnt1Y777H expression increases KNa current at several negative voltage steps (−50, −40, and −10 mV) in FS GABAergic neurons, heterozygous expression of the same variant in FS GABAergic neurons caused no significant differences in KNa currents compared with those of WT (Figure 2B2, C2).

Heterozygous Kcnt1Y777H expression does not alter synaptic connectivity or the excitation–inhibition balance

In addition to alterations in the intrinsic passive and active membrane properties of cortical neurons with homozygous Kcnt1Y777H expression, we previously showed evidence of altered synaptic connectivity and activity, leading to hypersynchronous, hyperexcitable YH-HOM networks; more specifically, we found an increase in homotypic coupling between glutamatergic [excitatory–excitatory (E–E)] and GABAergic [inhibitory–inhibitory (I–I)] neuron pairs, and an increase in the frequency of spontaneous excitatory postsynaptic currents (sEPSCs), accompanied by an increase in the E/I ratio, onto YH-HOM glutamatergic cortical neurons (Shore et al., 2020). First, to determine whether there are similar changes in synaptic connectivity in YH-HET networks, we performed paired recordings of glutamatergic (excitatory, E) and GABAergic (inhibitory, I) neurons and alternatively stimulated each neuron at 0.1 Hz to test baseline connection probability and strength at the four possible motifs (E–E, I–E, E–I, and I–I). Connection probability was not altered in YH-HET networks at any of the motifs tested (Figure 3A14, left bar graphs), and the amplitudes of the evoked postsynaptic currents (ePSCs) between connected neurons were not different between genotypes for any of the four connection types (Figure 3A14, right bar graphs), indicating grossly normal synaptic interactions among glutamatergic and GABAergic neurons in YH-HET networks. Next, to assess potential alterations in synaptic activity, we recorded spontaneous postsynaptic currents (sEPSCs and sIPSCs) onto voltage-clamped glutamatergic and GABAergic neurons. Unlike the observation of an increase in sEPSC frequency onto YH-HOM glutamatergic neurons, there was no difference in sEPSC, or sIPSC, frequency onto YH-HET glutamatergic neurons (Figure 3B1). Furthermore, although we previously found no alterations in sPSC frequency onto YH-HOM GABAergic neurons, sEPSC and sIPSC frequencies were both slightly reduced onto YH-HET GABAergic neurons (Figure 3B2). Finally, to assess the net effect of altered sPSC activity onto YH-HET neurons, we calculated the E/I ratio, based on the relative frequency and size of the sPSCs, and found no difference in the E/I ratio onto either YH-HET neuron type (Figure 3B3). Thus, although heterozygous Kcnt1Y777H expression resulted in similar KNa current increases and neuronal physiology effects to those found with homozygous Kcnt1Y777H expression, the broad effects on synaptic connectivity and activity found in YH-HOM networks were absent in YH-HET networks, which likely results in the observed reduction in seizure incidence in heterozygous, relative to homozygous, mice.

Figure 4 with 3 supplements see all
Heterozygous Kcnt1Y777H expression differentially affects the intrinsic excitability of somatostatin (SST)- and parvalbumin (PV)-expressing GABAergic neurons.

(A) A schematic diagram illustrates the strategy for generating fluorescently labeled GABAergic subtype-specific neurons. YH-HET mice were crossed to vasoactive intestinal polypeptide (VIP)-, SST-, or PV-Cre mice, and the resulting P0 wildtype (WT) and YH-HET littermate pups were used to isolate and culture cortical neurons. At DIV 1, neurons were infected with AAV-CamKIIa-GFP to label glutamatergic neurons, and AAV-hSyn-DIO-mCherry to label Cre-expressing neurons. At DIV 13–17, whole-cell, patch-clamp electrophysiology was performed on mCherry+/GFP neurons. (B1–B3) On the left, representative responses to step currents are shown for VIP-, SST-, and PV-expressing WT (black) and YH-HET (colors) neurons (top to bottom). For each neuron type, the superimposed dark traces illustrate the input resistance (in response to a hyperpolarizing step) and the rheobase (the first trace with an action potential (AP) in response to a depolarizing step), and the light trace shows the first step current response to induce repetitive AP firing across the step. Above the superimposed traces, the first AP of each rheobase trace is shown (same vertical scale, increased horizontal scale). On the right, bar graphs show quantification of the membrane properties and AP parameters for each neuron type (VIP, SST, and PV, top to bottom) for WT (gray) and YH-HET (colors) groups, with individual neuron measurements overlaid in scatter plots. The p-values are shown above each graph where p < 0.05. (C1–C3) For VIP-, SST-, and PV-expressing neurons (left to right), representative traces are shown at low, medium, and high current steps, and the line graphs below show the number of APs (mean ± SEM) per current injection step in WT (black) and YH-HET (colors) neurons. Statistical significance was tested using generalized linear mixed models, and p-values are shown above each graph where p < 0.05. Data from this figure are from the following mouse pup (N) and neuron (n) sample sizes: VIP WT (N=3, n=50) and YH-HET (N=4, n=48), SST WT (N=4, n=45) and YH-HET (N=5, n=46), and PV WT (N=3, n=23) and YH-HET (N=4, n=25).

Figure 4—source data 1

File containing data used to generate the graphs in Figure 4.

https://cdn.elifesciences.org/articles/92915/elife-92915-fig4-data1-v1.xlsx

Heterozygous Kcnt1Y777H expression differentially affects the intrinsic excitability of SST- and PV-expressing GABAergic neurons

Next, we sought to determine which GABAergic subtypes are most impacted by heterozygous Kcnt1Y777H expression. About 80–90% of cortical GABAergic neurons fall into three, largely non-overlapping populations that can be identified by their expression of unique markers: the Ca2+-binding protein PV (~40%), the neuropeptides SST (~30%), and VIP (~15%) (Rudy et al., 2011; Tremblay et al., 2016). The majority of PV-expressing neurons have been characterized as FS, and VIP-expressing as NFS, whereas SST-expressing neurons, although largely thought to show NFS firing properties, also contain a population that exhibits an FS-like phenotype (Large et al., 2016; Ma et al., 2006). KCNT1 is expressed at higher levels in both human and mouse cortical GABAergic neurons expressing PV and SST, than in those expressing VIP (Gertler et al., 2022; Shore et al., 2020). Based on the expression profile of KCNT1, and our findings that homozygous and heterozygous expression of the Kcnt1 GOF variant strongly reduced the excitability of GABAergic neurons with NFS firing properties, we hypothesized that the SST-expressing neurons are the most vulnerable to the effects of KCNT1 GOF. To test this hypothesis, we crossed PV-, SST-, and VIP-Cre mouse lines to the Kcnt1Y777H mouse line and cultured neurons from the cortices of WT and YH-HET littermate progeny (Figure 4A and Figure 4—figure supplement 1A). We infected the cultured neurons with AAV-CaMKIIa-GFP, to mark glutamatergic neurons, and AAV-hSyn-DIO-mCherry, to mark Cre recombinase-expressing GABAergic neurons, and performed whole-cell, patch-clamp electrophysiology at DIV 13–17 on GFP/mCherry+ neurons from each group.

First, we measured the intrinsic membrane properties and AP shape parameters of the three GABAergic subtypes from the WT control groups to verify that they accurately reflected electrophysiological behaviors of these subtypes from previous ex vivo recordings (Taniguchi et al., 2011). As expected, the VIP neurons showed a relatively large input resistance, small rheobase, wide AP half-width, small AHP, and low firing rate (Figure 4—figure supplement 1B, C, purple); in contrast, PV neurons showed a small input resistance, large rheobase, narrow AP half-width, large AHP, and high firing rate (Figure 4—figure supplement 1B, C, orange). For SST neurons, the values measured for input resistance, rheobase, AP half-width, AHP, and firing rate were all intermediate to those of VIP and PV neurons (Figure 4—figure supplement 1B, C, blue). Moreover, as reported previously, SST neurons showed the most hyperpolarized AP threshold of the three groups. Together, these data demonstrate the ability of cortical GABAergic neuron subtypes to retain their characteristic ex vivo passive and active membrane properties in vitro.

Next, we assessed the effects of the Kcnt1Y777H variant on the passive and active membrane properties of each GABAergic subtype. Current-clamp recordings from YH-HET VIP neurons revealed no significant effect of the variant on any of the membrane or AP properties measured (Figure 4B1). Conversely, YH-HET SST neurons showed a strong decrease in input resistance, with an accompanying increase in rheobase current, relative to those of WT SST neurons (Figure 4B2), similar to the hypoexcitable membrane phenotype observed in the YH-HET NFS neurons, without altering AP shape parameters. YH-HET SST neurons also showed a reduction in the membrane time constant and an increase in membrane capacitance, which was accompanied by an increase in soma size (Supplementary file 2 and Figure 4—figure supplement 2), compared with those of WT SST neurons. Unexpectedly, YH-HET PV neurons exhibited a decrease in the rheobase current compared with that of WT (Figure 4B3), and an increase in AP amplitude (Supplementary file 2), suggesting the Kcnt1Y777H variant increases PV neuron excitability.

Next, we measured AP firing frequency with incremental, 500 ms current steps in each of the three GABAergic subtypes. WT neurons showed AP firing frequencies similar to those reported previously from ex vivo recordings of neurons from the three Cre lines (Taniguchi et al., 2011), with VIP showing the lowest maximal firing frequency, PV the highest, and SST intermediate between VIP and PV (Figure 4C1–3 and Supplementary file 2). Consistent with a lack of any effects on membrane and AP shape properties, the AP firing frequencies across increasing current steps were indistinguishable between WT and YH-HET VIP neurons (Figure 4C1). As expected, based on their hypoexcitable membrane properties, the YH-HET SST neurons fired fewer APs across all current steps relative to WT SST neurons (Figure 4C2). In contrast to SST neurons, but consistent with their decreased rheobase current, YH-HET PV neurons fired more APs across all current steps relative to their WT counterparts (Figure 4C3). Notably, although these experiments were performed at room temperature (~22°C), and increasing temperatures to 35°C altered multiple neuronal physiology parameters (Figure 4—figure supplement 3A), both WT and YH-HET PV neurons responded similarly to increased temperature (Figure 4—figure supplement 3B), suggesting that the observed phenotypes are not temperature dependent. Together, these data showed that, as hypothesized, KCNT1 GOF indeed strongly reduces the excitability of SST neurons, but unexpectedly, it also causes a hyperexcitable effect in PV neurons; thus, the same ion channel mutation can lead to opposite effects on excitability in the two largest GABAergic neuron subtypes.

The Kcnt1Y777H variant increases KCNT1-mediated currents across subthreshold voltages in SST- and PV-expressing GABAergic neurons

Are the observed differential effects of KCNT1 GOF on GABAergic neuronal physiology due to distinct patterns of KNa current increases among GABAergic neuron subtypes? To answer this question, we first recorded KNa currents from GABAergic neurons cultured and labeled as described above, by applying voltage steps to voltage-clamped neurons and comparing the delayed outward current before and after the addition of TTX (Figure 5—figure supplement 1A1–3). In all three subtypes, for both WT and YH-HET neurons, we observed KNa currents beginning around −10 mV and increasing with depolarization (Figure 5—figure supplement 1B1–3). For YH-HET VIP neurons, pairwise comparisons to assess voltage-dependent differences showed that their KNa currents were not different from those of WT at any voltage step (Figure 5—figure supplement 1B1, C1). On the other hand, YH-HET SST neurons showed significant increases in KNa currents compared with those of WT across multiple subthreshold voltage steps, including −60, −50, and −40 mV (Figure 5—figure supplement 1B2, C2), similar to those observed in NFS GABAergic neurons with both heterozygous (Figure 2) and homozygous expression of the Kcnt1Y777H variant (Shore et al., 2020), indicating a direct current-to-phenotype relationship in YH-HET SST neurons. Somewhat unexpectedly, pairwise comparisons showed that KNa currents were not different between YH-HET and WT PV neurons at any voltage step (Figure 5—figure supplement 1B3, C3).

The lack of an increase in TTX-sensitive currents in PV neurons, despite alterations in rheobase, AP amplitude, and AP firing frequency, suggests that either a TTX-insensitive Na+ source activates KCNT1, or that compensatory alterations in an opposing current mask an increase in KNa and lead to the changes in AP firing. In past studies, the lack of selective KCNT1-specific inhibitors necessitated the use of indirect methods, such as TTX application or Na+ replacement, to estimate the magnitude of KNa. However, more recently, we identified and validated a small-molecule, selective KCNT1 channel inhibitor termed VU0606170 or VU170 (Spitznagel et al., 2020). To further validate the specificity of this small molecule, we applied voltage steps to voltage-clamped neurons lacking KCNT1 and KCNT2 channels, isolated and cultured from Kcnt1−/−; Kcnt2−/− double knockout mice (Martinez-Espinosa et al., 2015), and we compared the delayed outward current before and after the addition of either 10 µM VU170 or 0.5 µM TTX. This analysis indicated a non-specific outward VU-sensitive current that started around −10 mV and peaked at +50 mV (~1 nA peak current compared with ~3 nA in WT neurons), which was not present using TTX subtraction (Figure 5—figure supplement 2A). Across negative potentials, there was an inward TTX-sensitive current, which again is likely due to the persistent Na+ current, whereas there was little to no outward VU-sensitive current (Figure 5—figure supplement 2B), validating the utility of VU170 in isolating KNa currents across this voltage range.

To better assess KCNT1-mediated currents in GABAergic subpopulations and disentangle potential confounds of using TTX, particularly across negative potentials, we applied the same voltage step protocol as in the TTX subtraction experiments but applied 10 µM VU170 instead. In all three WT GABAergic neuron subtypes, subtraction of the VU170 trace from the control trace revealed nA-sized outward currents at depolarized potentials, and in YH-HET neurons, the overall VU170-sensitive current was increased relative to those of WT, as measured by a significant effect of genotype using a linear model (Figure 5A1–3, B1–3). Pairwise comparisons at each voltage step showed voltage-dependent differences in current increases among the YH-HET neuron subtypes. For YH-HET VIP neurons, a significant increase in the VU170 current was only observed at +50 mV (Figure 5B1), whereas subthreshold currents were indistinguishable from those of WT (Figure 5C1). Previously, we similarly observed KNa current increases only at more positive potentials in YH-HOM glutamatergic neurons, and like YH-HET VIP neurons, their membrane and AP properties were unaltered by expression of the YH variant (Shore et al., 2020). Conversely, in YH-HET SST neurons, significant increases occurred at more negative voltage steps, from −60 to −30 mV (Figure 5C2). These changes were similar to those observed with TTX treatment, but slightly larger, possibly due to the lack of the counteracting effect of the persistent Na+ current, which is also blocked by TTX. In contrast to the TTX results, YH-HET PV neurons showed an increase in VU170-sensitive currents, with significant increases from −70 to −50 mV (Figure 5C3). Taken together, these data identify distinct patterns of KNa current increases among GABAergic subtypes, and for VIP and SST neurons, these current increases are consistent with the observed effects of KCNT1 GOF on neuronal physiology. On the other hand, PV neurons showed subthreshold-specific KNa current increases that were highly similar to, and overlapping with, those of SST neurons; thus, differential KNa current increases alone likely do not account for the opposite effects of KCNT1 GOF on physiology observed in these two neuron types.

Figure 5 with 2 supplements see all
The Kcnt1Y777H variant increases KCNT1-mediated currents across subthreshold voltages in somatostatin (SST)- and parvalbumin (PV)-expressing GABAergic neurons.

(A1–A3) Representative traces in control (top), 10 µM VU170 (middle), and the difference current (bottom) calculated by subtracting the membrane current response to voltage steps (−80 to +50 mV) from a holding potential of −70 mV in VU170 from the response in control external solution in vasoactive intestinal polypeptide (VIP)-, SST-, and PV-expressing, wildtype (WT) (black) and YH-HET (colors) neurons. To include all of the representative traces in the figures, and prevent overlap of the traces, the large inward sodium currents were removed from each set of traces using the masking tool in Adobe Illustrator. (B1–B3) Summary data show the KCNT1 current (mean ± SEM) for each voltage step in VIP-, SST-, and PV-expressing, WT (black and gray) and YH-HET (colors) neurons. The p-values are shown on each graph where p < 0.05, and the n values are the number of neurons recorded for each group. (C1–C3) Plots of the KNa current (mean ± SEM) for each voltage step from −80 to 0 mV in WT (black and gray) and YH-HET (colors) neurons to illustrate the values that are too small to be seen on the graphs in B1–B3. The shaded red areas in C2 and C3 indicate the subthreshold voltage range with significantly higher KNa currents (p < 0.05) in YH-HET relative to WT neurons. Statistical significance for IV plots was tested using generalized linear mixed models with genotype and voltage step as fixed effects followed by pairwise comparisons at each level. Asterisks indicate where p < 0.05 (*).

Figure 5—source data 1

File containing data used to generate the graphs in Figure 5.

https://cdn.elifesciences.org/articles/92915/elife-92915-fig5-data1-v1.xlsx

Compartmental models of KCNT1 GOF in SST, but not PV, neurons are consistent with experimental data

The VU170-subtraction experiments showed that YH-HET SST and PV neurons have similar subthreshold increases in KCNT1-mediated currents, even though they exhibited opposing effects on neuron excitability and AP generation, and that YH-HET VIP neurons have suprathreshold increases in KCNT1-mediated currents with no effects on neuron physiology. Because GABAergic subtypes exhibit varying morphologies and express unique repertoires of ion channels, which are known to give rise to their characteristic membrane and AP firing properties, we hypothesized that at least some of the observed differential effects of KCNT1 GOF, in particular the opposite effects in SST and PV neurons, are due to these inherent, neuron-type-dependent differences. To test this hypothesis, we simulated the effect of KCNT1 GOF in compartmental models of these three cortical neuron types. We used a KCNT1 conductance with the Na+ dependence constrained by prior studies in neurons (EC50 = 40 mM, slope 3.5; see Materials and methods) and the voltage dependence based on the activation curves from our own experimental data of the VU170-sensitive current in each subtype (Figure 6A). The kinetics of the model current were set by measuring the onset time course of the VU170-sensitive current in outside-out membrane patches of each neuron type (Figure 6B, C). This conductance was inserted into compartmental models of 10 neurons per subtype, representing a variety of morphological and electrical properties of each subtype (Markram et al., 2015; https://bbp.epfl.ch/nmc-portal/downloads.html). Because the Y796H variant was previously shown to increase the Na+ sensitivity of the channel, we modeled the GOF effect by reducing the EC50 for Na+ activation to two levels (35 and 30 mM), which resulted in moderate KNa current increases above WT levels (Figure 6D).

Figure 6 with 2 supplements see all
Compartmental models of KCNT1 gain-of-function (GOF) in somatostatin (SST), but not parvalbumin (PV), neurons are consistent with experimental data.

(A) Activation curves for vasoactive intestinal polypeptide (VIP), SST, and PV neurons used to model the KCNT1 channel in each neuron type. (B) Representative traces of the response of an outside-out membrane patch pulled from an SST neuron in control external solution (top) and after application of 10 µm VU170 (bottom). (C) Representative trace of the VU170-sensitive current in an outside-out patch pulled from an SST neuron with a single exponential fit (red curve) overlaid and summary data showing the time constant (mean ± SEM) obtained from these fits. (D) Simulated traces showing the KCNT1-mediated current in model neurons at three levels of Na+-sensitivity (Con-40 mM, GOF-35 mM, and GOF-30 mM). (E1, F1, and G1) Simulated traces from model VIP (E1; purple), SST (F1; blue), and PV (G1; yellow) neurons in response to 500 ms current injections at three levels of Na+ sensitivity [control (Con), and two levels of KCNT1 GOF]. Representative traces are shown at increasing current steps from bottom to top for each level. (E2, F2, and G2) Summary data from 10 model VIP (E2; purple), SST (F2; blue), and PV (G2; yellow) neurons showing (from left to right) the number of action potentials (APs) at different current steps (FI plot), input resistance, and rheobase. The bar graphs (mean ± SEM) are overlaid with scatter plots of individual neuron measurements. Statistical significance was tested using a repeated measures analysis of variance (ANOVA). Asterisks indicate where p < 0.05 (*), p ≤ 0.01 (**), and p ≤ 0.001 (***).

Figure 6—source data 1

File containing data used to generate the graphs in Figure 6.

https://cdn.elifesciences.org/articles/92915/elife-92915-fig6-data1-v1.xlsx

Consistent with our experimental data, introducing KCNT1 GOF at the lower level (EC50 = 35 mM) into model VIP neurons did not alter their AP firing rate, input resistance, or rheobase, whereas at the higher level (EC50 = 30 mM), there were small changes in input resistance (40 mM: 266.5 ± 28.2; 30 mM: 264.8 ± 28.0, p = 0.012) and rheobase (40 mM: 78.7 ± 11.6; 30 mM: 80.4 ± 11.1, p = 0.014), but these changes were not sufficient to affect the AP firing rate (Figure 6E1, E2, Supplementary file 3, and Figure 6—figure supplement 1A). On the other hand, model SST neurons with KCNT1 GOF at both levels fired fewer APs per current step as the GOF was increased, and showed significantly reduced input resistances, higher rheobases, and lower AP firing rates (Figure 6F1, F2 and Supplementary file 3), results that agree with our experimental observations. In contrast to experimental data, but similar to model SST neurons, model PV neurons responded to KCNT1 GOF with decreased input resistance, increased rheobase, and a reduced AP firing rate (Figure 6G1, G2 and Supplementary file 3), although the magnitude of these effects were smaller than those in model SST neurons (Figure 6—figure supplement 1A). These data suggest that the increased excitability observed in YH-HET PV neurons is not simply due to an intrinsic property of this GABAergic subtype, but instead results from an indirect mechanism (e.g. a compensatory response like an increase in Na+ channels) or depends on a feature of KCNT1 function not captured by the model.

Lastly, we hypothesized that the lack of GOF effects on VIP and glutamatergic neuron physiology is due to the altered kinetics of their KCNT1 channel activation curves, in particular their right shifted V50 and decreased slope, relative to those of SST or PV neurons (Figure 6A). To test this hypothesis, we performed simulations in which the activation curve parameters (V50 and slope) measured in SST neurons were inserted into VIP and glutamatergic neurons, with the Na+ EC50 set to 30 mM to simulate KCNT1 GOF (Figure 6—figure supplement 2A1, B1, blue traces). Inserting KCNT1 channels with SST kinetics into VIP and glutamatergic neurons indeed enhanced the GOF effects on input resistance and rheobase, and importantly, resulted in a significantly decreased AP firing rate relative to control neurons for both neuron types (Figure 6—figure supplement 2A2, B2, Supplementary file 3, and Figure 6—figure supplement 1B). This model-based evidence suggests that the relative sensitivity of SST and PV neurons, and resistance of VIP and glutamatergic neurons, to KCNT1 GOF is due to the differences in voltage dependence of the KNa current in each subtype.

The persistent Na+ current is increased by the Kcnt1Y777H variant in PV, but not SST, neurons

The modeling results suggest that a subthreshold increase in the KNa current alone is not sufficient to account for the alterations in PV neuron excitability. Moreover, the finding of an increase in the KCNT1-mediated current in YH-HET PV neurons when measured with VU170, but not TTX, isolation suggests there may be a compensatory upregulation of an opposing current that masks the increase in KNa and leads to the unexplained increase in AP firing. The persistent Na+ current (INaP) is active on the same time scale as KNa and was previously shown to provide the Na+ source for KNa (Hage and Salkoff, 2012); therefore, we hypothesized that KCNT1 GOF causes an increase in INaP in PV neurons that enhances their excitability. To test this hypothesis, we measured INaP in SST and PV neurons by applying TTX during slow voltage ramp protocols (20 mV/s) designed to isolate INaP from both the transient Na+ current and the KNa current (Figure 7—figure supplement 1). In SST neurons, INaP did not differ between WT and YH-HET neurons, either in the shape of the response (Figure 7A, B), or the peak amplitude (Figure 7B). In PV neurons, however, the peak amplitude of INaP was significantly increased by the Kcnt1Y777H variant (Figure 7C, D). Interestingly, the mean peak amplitude of INaP in WT PV neurons was 70% larger than that in WT SST neurons (−1.42 ± 0.16 to −0.85 ± 0.07 pA/pF; Figure 7B, D), suggesting there may be differences in sodium channel expression, localization, or regulation inherent to each neuron type that confer their differential response to KCNT1 GOF.

Figure 7 with 2 supplements see all
The persistent Na+ current is increased by the Kcnt1Y777H variant in parvalbumin (PV), but not somatostatin (SST), neurons.

(A) Representative traces of wildtype (WT) (left) and YH-HET (right) SST neurons in response to slow voltage ramp in control (dark gray) and 7 s after application of 0.5 nM tetrodotoxin (TTX) (light gray) with the difference current (INaP) plotted on the same scale. (B) INaP IV curves of WT (gray) and YH-HET (blue) SST neurons constructed from averaging the ramp-evoked difference current (mean ± SEM) at 5 mV intervals (left), and a bar graph with overlaid scatter plot showing the peak negative value for each neuron (right). (C) Representative traces of WT (left) and YH-HET (right) PV neurons in response to slow voltage ramp in control (dark gray) and 7 s after application of 0.5 nM TTX (light gray) with the difference current (INaP) plotted on the same scale. The upper traces and difference currents are plotted on different scales. (D) INaP IV curves of WT (gray) and YH-HET (orange) PV neurons constructed from averaging the ramp-evoked difference current (mean ± SEM) at 5 mV intervals (left), and a bar graph with overlaid scatter plot showing the peak negative value for each neuron (right). (E) Simulated traces from a model PV neuron in response to 500 ms current injections with control levels of KCNT1 (black traces) and KCNT1 gain-of-function (GOF) (Na+ EC50 = 35 mM) with a twofold increase in INaP (orange traces). Representative traces are shown at increasing current steps from bottom to top for each level. (F) FI plot shows the increase in action potential (AP) firing (left), and a bar graph with overlaid scatter plot of individual neuron values shows the decrease in rheobase associated with modeling KCNT1 GOF (Na+ EC50 = 35 mM) together with the increase in INaP. For modeling data, statistical significance was tested using a repeated measures ANOVA. Asterisks indicate where p < 0.05 (*) and p ≤ 0.001 (***).

Figure 7—source data 1

File containing data used to generate the graphs in Figure 7.

https://cdn.elifesciences.org/articles/92915/elife-92915-fig7-data1-v1.xlsx

To examine whether the observed increase in INaP in YH-HET PV neurons could account for the increase in AP firing, we again simulated the effect of KCNT1 GOF (Na+ EC50 = 35 mM) on PV neuron activity, but this time included an increase in INaP in the compartmental models. Indeed, an increase in INaP conductance, similar to what was seen in the experimental results (twofold), was sufficient to increase the number of APs fired in response to increasing current steps (Figure 7E, F and Supplementary file 3), even in the face of the higher level of KCNT1 GOF (30 mM; Supplementary file 3 and Figure 7—figure supplement 2). Also, like the experimental data, the rheobase current was decreased (Figure 7F and Figure 7—figure supplement 2) and the AP height was increased (80.4 ± 0.7 vs. 82.1 ± 0.8 mV). These results suggest that the differential effects on AP firing in SST and PV neurons can be accounted for by the absence or presence of a secondary increase in INaP.

YH-HET SST neurons show increased chemical and electrical coupling and receive increased excitatory input

We previously showed that homozygous expression of the Kcnt1Y777H variant increased connections between GABAergic neurons (Shore et al., 2020), but heterozygous expression did not (Figure 3). Because heterozygous Kcnt1Y777H variant expression caused the strongest excitability impairments in SST neurons, we hypothesized that alterations in synaptic connectivity and activity may be more likely to occur in this neuronal population. To test this hypothesis, we recorded from pairs of WT or YH-HET SST neurons as described above to measure connection probability and strength. Indeed, similar to the increase observed in I–I connections in YH-HOM networks, we found an increase in homotypic synaptic connections of SST neurons in YH-HET networks (30/40 connections) relative to those in WT (15/40 connections; Figure 8A). The amplitudes of the evoked postsynaptic currents (ePSCs) between connected SST neurons were not significantly different between the YH-HET and WT groups (Figure 8B).

YH-HET somatostatin (SST) neurons show increased chemical and electrical coupling and receive increased excitatory input.

(A, B) Evoked postsynaptic currents (PSCs) were recorded from SST neuron pairs by stimulating each neuron at 0.1 Hz and recording the response onto the partner. (A) Bar graph shows the connection probability (mean + SEM) between SST neurons (wildtype [WT], gray; YH-HET, blue; numbers on bars represent connected pair number/recorded pair number). (B) On the left, example traces of evoked IPSCs [individual IPSCs (light) overlaid by averaged IPSCs (dark)], and on the right, a graph of connection strength between SST neurons (WT, gray; YH-HET, blue; individual measurements and summary violin plots). (C1) A schematic illustrates representative responses (presynaptic, black; postsynaptic, red) between chemically coupled (upper two panels) and electrically coupled (lower two panels) SST neurons following 100 pA (left two panels) and action potential (AP) (right two panels) stimulation. (C2) Summary data of four possible connection motifs (not coupled, chemical: one-way, chemical: two-way, and electrical) tested among WT (gray box) and YH-HET (blue box) SST neuron pairs (20 pairs/group). (D) On the left, example traces of spontaneous EPSCs (sEPSCs) recorded onto SST neurons (WT, black; YH-HET, blue). On the right, a graph shows individual neuron measurements and summary violin plots of the sEPSC frequency onto SST neurons (WT, gray; YH-HET, blue). All significant p-values are displayed at the top of each graph.

Figure 8—source data 1

File containing data used to generate the graphs in Figure 8.

https://cdn.elifesciences.org/articles/92915/elife-92915-fig8-data1-v1.xlsx

There are two main types of synaptic coupling between neurons: chemical, which is mediated by neurotransmitter release, and electrical, which is mediated by gap junctions. To test for alterations in each type of synaptic coupling due to expression of the Kcnt1 variant, we recorded from 20 pairs of WT or YH-HET SST neurons in close proximity (<100 µm apart). Under current-clamp conditions, we injected a series of hyperpolarizing and depolarizing current steps into one neuron and assessed whether the current induced a simultaneous voltage deflection in the paired, non-injected neuron (Figure 8C1; 100-pA-evoked response). We then evoked a train of APs in one neuron and assessed the AP-induced voltage changes in the paired, non-injected neuron (Figure 8C1; AP-evoked response). SST pairs were considered to be chemically coupled if the AP trains in one neuron induced corresponding IPSCs, without inducing voltage deflections in response to the current steps, onto the paired neuron (Figure 8C1; top panels). SST pairs were considered to be electrically coupled if the current steps injected into one neuron induced simultaneous voltage deflections in the paired neuron (Figure 8C1; bottom panel, left). Electrically coupled SST neurons also frequently showed AP-evoked spikelets onto paired neurons due to low-pass filtering (Figure 8C1; bottom panel, right), which results in a greater attenuation of the high frequency portion (spike), than the low-frequency portion (AHP), of an AP as it passes through an electrical synapse.

Of the 20 WT SST neuron pairs tested, 12 were coupled, and the majority (9/12) of those were one-way chemical connections (Figure 8C2). Of the 20 YH-HET SST neuron pairs tested, 17 were coupled, and the majority (13/17) of those were two-way, or bidirectionally, connected (Figure 8C2). Of the 3 bidirectionally connected WT SST neuron pairs, 2 were chemical and 1 was electrical, whereas of the 13 bidirectionally connected YH-HET SST neuron pairs, 7 were chemical and 6 were electrical (Figure 8C2). Thus, these data suggest that heterozygous Kcnt1Y777H expression increases reciprocal connectivity among SST neurons, of both the chemical and electrical sort.

Finally, although we previously found no alterations in the sEPSC frequency onto the total population of YH-HOM GABAergic neurons, there was an increase in the sEPSC frequency onto those with an NFS phenotype (Shore et al., 2020), suggesting there may be a compensatory increase in excitatory drive onto NFS YH-HOM GABAergic neurons to offset the effects of their decreased membrane excitability. To assess whether there is a similar increase in sEPSC frequency onto SST-expressing YH-HET neurons, which showed a similar decrease in membrane excitability to that of NFS YH-HOM GABAergic neurons, we recorded sEPSCs onto voltage-clamped WT and YH-HET SST neurons. Indeed, there was an increase in sEPSC frequency onto YH-HET SST neurons compared with that of WT (Figure 8D), suggesting a compensatory increase in excitatory drive onto the most impaired GABAergic subtype.

Acute cortical slice recordings confirm the reduced intrinsic excitability of YH-HET SST neurons

Of the three GABAergic neuron populations assessed, SST-expressing neurons showed the strongest impairments, both direct and indirect, downstream of the heterozygous Kcnt1Y777H variant. Importantly, the observed effects on YH-HET SST neuron physiology were consistent with those that would be expected, based on YH-HET SST subthreshold KNa current increases (Figure 5—figure supplement 1C2, and Figure 5C2), and predicted, based on SST KCNT1 GOF neuron modeling data (Figure 6F1, F2). Thus, to test whether the most significant physiological alterations identified in cortical neuron cultures are also present in an experimental preparation with a more organized network, we crossed YH HET mice with homozygous GIN (GFP-expressing inhibitory neurons) mice, which express GFP in a subpopulation of SST-expressing neurons of the hippocampus and cortex (Ma et al., 2006; Oliva et al., 2000), and performed electrophysiological recordings in acute brain slices from WT and YH-HET progeny.

First, we assessed the effects of the heterozygous Kcnt1Y777H variant on the passive and active membrane properties by performing whole-cell, current-clamp recordings of layer 2/3, GFP-expressing neurons in motor and somatosensory cortical regions of slices prepared from P21 to P30 mice (Figure 9A). Incremental current injections to elicit APs demonstrated a strong impairment in AP generation downstream of the heterozygous Kcnt1Y777H variant, as the YH-HET GFP-expressing neurons fired fewer APs across all current steps than the WT GFP-expressing neurons, similar to that observed in the YH-HET SST cultured neurons (Figure 9B, C). Although YH-HET GFP-expressing neurons in slice did not show a significant decrease in input resistance relative to those from WT, they did show a large increase in rheobase current, without alterations in AP shape (Figure 9D). Thus, we confirmed the main electrophysiological finding from culture—the reduced excitability of YH-HET SST neurons—in acute slices from YH-HET juvenile mice.

Acute cortical slice recordings confirm the reduced intrinsic excitability of YH-HET SST neurons.

(A) An inverted monochrome image illustrates the recording scheme from GFP-expressing neurons in acute slices from P21 to P30 GIN mice that express GFP in a subset of SST-positive neurons. (B) Representative responses to current steps are shown for wildtype (WT) (black) and YH-HET (blue) to three, equivalent 1 s current steps. (C) Plot of the action potential (AP) frequency (mean ± SEM; 25 neurons/group) per current injection step shows that YH-HET GFP-expressing neurons (blue) fire fewer APs than those of WT (gray) across a range of current inputs. (D) Bar graphs show quantification of the membrane properties and AP parameters for WT (gray) and YH-HET (blue) GFP-expressing neuron groups, with individual neuron measurements overlaid in scatter plots. Relevant p-values are shown in gray boxes on or above graphs.

Figure 9—source data 1

File containing data used to generate the graphs in Figure 9.

https://cdn.elifesciences.org/articles/92915/elife-92915-fig9-data1-v1.xlsx

Discussion

More than a decade ago, autosomal dominant mutations were identified in the sodium-gated potassium channel KCNT1 in multiple patients with severe, childhood epilepsy syndromes (Barcia et al., 2012; Heron et al., 2012). KCNT1-related epilepsy patients suffer not only with frequent, early-onset seizures, but also with cognitive impairments, movement disorders, and sometimes additional behavioral and/or psychiatric problems (Bonardi et al., 2021). Unfortunately, after over 10 years of research efforts, KCNT1-related epilepsies remain highly refractory to current anti-seizure medications (Bonardi et al., 2021); thus, a better understanding of the pathological mechanisms underlying KCNT1-related epilepsies—from mutated gene to altered K+ current to altered neuronal physiology to altered neural network to seizure—is imperative for advancing therapeutic strategies to improve seizure control and enhance patient quality of life.

Heterozygous vs. homozygous KCNT1 GOF variant effects

Despite the heterozygous nature of KCNT1 GOF variants in the overwhelming majority of KCNT1-related DEE patients, research efforts, including our own, have largely focused on homozygous GOF variant effects on channel function and neuronal physiology (Gertler et al., 2019; Kim et al., 2014; McTague et al., 2018; Mikati et al., 2015; Milligan et al., 2014; Quraishi et al., 2019; Shore et al., 2020; Tang et al., 2016). Heterozygous KCNT1 GOF variant expression likely results in the formation of heteromeric KCNT1 channels, consisting of both WT and mutant subunits, whose characteristics and kinetics may differ from those of homomeric KCNT1 channels; thus, it is critical to distinguish between GOF variant effects in heteromeric and homomeric KCNT1 channels to identify the pathogenic mechanisms of KCNT1 GOF variants in DEEs. Recent work in heterologous cells has shown that KCNT1 GOF heteromeric channels, with WT and mutant subunits, exhibit KNa current increases that lie between those of WT and KCNT1 GOF homomeric channels (Cole et al., 2021; Dilena et al., 2018; Rizzo et al., 2016). Furthermore, other recent studies have similarly shown that heterozygous Kcnt1 GOF variant expression in neurons causes effects on KNa current and excitability that are intermediate to those of WT and homozygous variant-expressing neurons (Gertler et al., 2022; Wu et al., 2024).

Here, we assessed the effects of heterozygous expression of Kcnt1Y777H on KNa currents, neuronal physiology, and synaptic connectivity among cortical neuron subtypes in mice, and compared the effects to those observed previously with homozygous expression of the same variant (Shore et al., 2020). We found that the heterozygous YH variant caused similar effects on KNa currents and neuronal physiology to those caused by the homozygous YH variant, including subthreshold-specific increases in KNa current, altered AP shape, and impaired AP firing of NFS GABAergic neurons, but with magnitudes intermediate to those of WT and YH-HOM neurons. At the network and whole-animal level, we previously showed that homozygous expression of the YH variant in mice increases homotypic synaptic connectivity (E–E and I–I) and the E/I ratio, resulting in hypersynchronous, hyperexcitable YH-HOM cortical networks and frequent seizures. Here, we found no evidence of similar network alterations in YH-HET cortical networks, which likely explains the infrequent seizures observed in the heterozygous YH mouse model, and together with the YH-HOM data, indicate a strong relationship between network abnormalities and seizure propensity downstream of the YH variant. Furthermore, these data suggest that heterozygous and homozygous KCNT1 variant expression cause similar, gene-dose-dependent GOF effects at the current and neuron level, but not at the network or whole-animal level.

Neuron-type-dependent KCNT1 GOF variant effects

Prior work has illustrated the importance of cell context in delineating the functional effects of ion channel variants on neuronal physiology. For instance, several studies using LOF channelopathy models of both sodium and potassium channels have identified excitability effects on one neuron type without effects on another (Hedrich et al., 2014; Soh et al., 2018; Tai et al., 2014; Yu et al., 2006). Other studies have shown that the same ion channel variant can even cause opposite effects on excitability in different neuron types (Makinson et al., 2016; Rush et al., 2006; Studtmann et al., 2022). Thus, understanding how KCNT GOF alters networks to lead to hyperexcitability and seizures requires a thorough evaluation of how the variant impacts each neuron type that participates in the network. With this goal in mind, we assessed the effects of heterozygous Kcnt1 GOF on KNa currents and AP generation among cortical glutamatergic neurons and all three major GABAergic neuron subtypes, including those expressing VIP, SST, and PV.

Using two methods to isolate and measure the KCNT1-mediated current, VU170 and TTX subtraction, we observed voltage-dependent differences in current increases among the YH-HET neuron types. YH-HET glutamatergic and VIP neurons showed KCNT1-mediated current increases across suprathreshold voltages, whereas YH-HET SST and PV neurons had current increases across subthreshold voltages. These neuron-type-dependent effects of KCNT1 GOF on KNa current increases are similar to those observed previously in YH-HOM, glutamatergic and GABAergic neuron subpopulations using TTX (Shore et al., 2020). Moreover, these results are similar to those reported in a recent study using a different KCNT1 GOF mouse model (human R474H, mouse R455H), which showed KNa current increases selectively across positive potentials in glutamatergic, but across positive and negative potentials in FS and NFS GABAergic, neurons (Wu et al., 2024). The mechanism underlying these neuron-type-dependent KCNT1 GOF effects on KNa current increases is unknown, however, we have observed differences even in WT KCNT1 channel activation curves between glutamatergic and VIP neurons (steeper slopes of activation) and SST and PV neurons (shallower slopes of activation), suggesting there are factors affecting KCNT1 channel kinetics that are inherent to each neuron type (Figure 6A). Future studies should investigate these potential factors including (1) differential expression of alternative KCNT1 splice forms, some of which are known to have different activation kinetics, (2) differential expression of other channels such as KCNT2, which can form heteromers with KCNT1 and alter its biophysical properties, and (3) differential expression and/or localization of, and/or coupling to, sodium channels that act as the source of KCNT1 channel activation (Chen et al., 2009; Hage and Salkoff, 2012; Joiner et al., 1998).

Consistent with the differential KCNT1 GOF effects on KNa currents, we observed a range of effects on membrane properties and AP generation among the cortical neuron populations. We observed no effects on YH-HET glutamatergic and VIP neurons, whereas YH-HET SST neurons showed reduced AP firing, with decreased input resistance and increased rheobase, and YH-HET PV neurons showed increased AP firing, with decreased rheobase. As a complementary approach, we performed in silico electrophysiology using our measured neuron-type-specific KCNT1 channel activation kinetics, with and without GOF, for each neuron type. For glutamatergic and VIP neurons, the steeper slopes of activation limited the effects of GOF on intrinsic excitability, whereas for SST neurons, the shallower slope of activation decreased the input resistance, increased the rheobase, and impaired AP generation downstream of KCNT1 GOF. Each of these modeling results are similar to those observed using in vitro electrophysiology, indicating direct KNa current-to-KCNT1 GOF phenotype relationships in these neuron types.

Conversely, for PV neurons, unlike the experimental observation of increased YH-HET PV neuron excitability, in silico electrophysiology predicted a slight reduction in PV neuron excitability downstream of KCNT1 GOF. In support of this in silico prediction, in a different KCNT1 GOF mouse model, heterozygous expression of the human L456F variant indeed reduced AP firing of PV neurons, without altering any other membrane properties or AP parameters (Gertler et al., 2022). The opposite effect of KCNT1 GOF on PV excitability between these two studies may simply result from variant-specific alterations in KCNT1 channel kinetics; however, both GOF variants showed a similar lack of effect on membrane properties and AP generation of glutamatergic neurons. Alternatively, the opposite effects could be due to the different experimental conditions used in the two studies, including (1) different preps and mouse ages (acute slices from P42 to P60 mice vs. DIV 13 to 17 cultured neurons from P0 pups) and (2) different brain regions (hippocampal vs. cortical). The idea of brain region-dependent effects of ion channel variants is not unprecedented, as a recent study showed that a potassium channel GOF variant causes opposite effects on excitability in the same neuron type from different brain regions (hippocampal CA1 vs. cortical layer 2/3 pyramidal neurons), and this opposite effect was suggested to be due to the compensatory upregulation of sodium channels in one neuron type but not the other (Varghese et al., 2023). Taken together, these findings illustrate the importance of interrogating not only multiple neuron types but also multiple brain regions to fully unravel the complexity underlying KCNT1 GOF-related neurodevelopmental disorders.

Evidence of potential neuron and network compensatory responses to KCNT1 GOF

In a healthy brain, there are multiple homeostatic compensation mechanisms to maintain neuronal and network activity at their proper physiological levels (Davis, 2013; Debanne et al., 2019; Debanne and Russier, 2019; Marder and Goaillard, 2006; Turrigiano, 2011; Turrigiano, 2012; Yang and Prescott, 2023), whereas in a brain with epilepsy-causing genetic mutations or injury, it is thought that failure of homeostatic compensation can result in hypersynchronous, hyperexcitable networks and, ultimately, seizures (Issa et al., 2023; Lignani et al., 2020; Staley, 2015). As YH-HET mice have only been observed to have infrequent seizures and YH-HET networks appear largely intact, it is plausible that there are adaptive or homeostatic mechanisms downstream of the YH variant that limit KCNT1 GOF effects largely to those observed at the current and neuron level. These regulatory mechanisms may include alterations in ion currents and/or synaptic input to restore proper AP shape or neuronal excitability, or alterations in chemical and/or electrical connectivity to stabilize neural networks.

Neuronal excitability is regulated by the inward and outward flow of opposing currents through sodium and potassium channels; thus, it is not surprising that mutations affecting these channels can lead to compensatory up- or downregulation of other ion channels or currents to maintain excitability and proper neuron function. In this study, our in silico electrophysiology predictions of YH-HET PV neuron excitability were opposite to those of our in vitro electrophysiology data; thus, we hypothesized that there may be a compensatory increase in an ion current that counteracts the increased KNa current selectively in YH-HET PV neurons. Accordingly, we identified a subthreshold increase in the persistent Na+ current, across a similar voltage range to the increased KNa current, in YH-HET PV, but not SST, neurons. Furthermore, in silico approaches indicated that this increased INaP was sufficient to overcome the effects of KCNT1 GOF and cause an overall increase in AP generation in YH-HET PV neurons, which aligned with our experimental data. Similar compensatory mechanisms have been identified in other models such as the downregulation of multiple potassium channels in a sodium channel (Scn2a) LOF mouse model of epilepsy, resulting in neuronal hyperexcitability (Zhang et al., 2021), or the upregulation of Na+ currents in response to increased potassium channel activity in a developing Xenopus neural circuit, resulting in restored intrinsic excitability and network stability (Pratt and Aizenman, 2007). Notably, another KCNT1 GOF model (Kcnt1-R455H) showed upregulation of a sodium channel (Nav1.6), accompanied by an increase in transient and persistent sodium currents, in Kcnt1-R455H cortical neurons, but the effects of Nav1.6 upregulation were not investigated (Wu et al., 2024).

As the persistent sodium current has been shown to act as a source of cytoplasmic sodium ions for KCNT1 channel activation in some neuron types (Hage and Salkoff, 2012), one might expect that the compensatory increase in INaP in YH-HET PV neurons would further increase, rather than counteract, KNa currents. Unfortunately, there is insufficient information on the relative locations of the INaP and KCNT1 channels, as well as the kinetics of sodium transfer to KCNT1 channels, among cortical neuron subtypes, and even less is known in the context of KCNT1 GOF neurons; thus, it is difficult to predict how alterations in one of these currents may affect the other. One plausible reason that increased INaP would not alter KNa currents in YH-HET PV neurons is that the particular sodium channels that are responsible for the increased INaP are not located within close proximity to the KCNT1 channels. Moreover, homeostatic mechanisms that modify the length and/or location of the sodium channel-enriched axon initial segment (AIS) in neurons in response to altered excitability are well described (Grubb and Burrone, 2010; Kuba et al., 2010); thus, it is possible that in YH-HET PV neurons, the length or location of the AIS is altered, leading to uncoupling of the sodium channels that are responsible for the increased INaP to the KCNT1 channels. Future studies will aim to further investigate potential mechanisms of neuron-type-specific alterations in NaP and KNa currents downstream of KCNT1 GOF.

In addition to the KCNT1 GOF current-mediated impairments in SST neuron excitability, we identified several potential compensatory YH-HET SST synaptic and network alterations. For instance, there was an increased frequency of sEPSCs onto YH-HET SST neurons, suggestive of a compensatory increase in excitatory input to counteract their reduced intrinsic excitability and increase their AP firing, as has been observed previously in hypoexcitable SST neurons in another epilepsy model (Halabisky et al., 2010). There was also an increase in chemical and electrical coupling between YH-HET SST neurons. Although SST neurons normally show a relatively low rate of homotypic chemical coupling, particularly in the adult cortex, more than half of nearby SST neuron pairs are coupled electrically (Amitai et al., 2002; Gibson et al., 1999; Gibson et al., 2005; Hu and Agmon, 2015; Urban-Ciecko and Barth, 2016). This coupling is thought to be important for fine tuning neural circuits by regulating such processes as synchronous AP firing, synaptic integration, and network rhythmicity (Alcamí and Pereda, 2019; Connors, 2017). The observed increase in electrical coupling should not only contribute to the reduced intrinsic excitability properties of individual YH-HET SST neurons, increasing their capacitance and decreasing their input resistance, but may also act as a homeostatic mechanism to restore synchronicity and stability to YH-HET SST networks (Lane et al., 2016; Parker et al., 2009).

Taken together, how might the YH-HET variant-induced alterations to SST and PV neurons, both direct and adaptive, ultimately contribute to neural network behavior and seizure propensity in YH-HET mice? The paucity of effects on synaptic activity and connectivity in YH-HET networks, relative to those of YH-HOM, suggests that the current- and neuron-level effects of the YH-HET variant are below some threshold required to induce broader network hyperexcitability and seizures. Moreover, as described above, several of the proposed homeostatic mechanisms, such as increased excitatory input onto, and connectivity between, SST neurons and increased INaP in PV neurons, should theoretically act to suppress pathological network activity in YH HET mice. However, predicting the downstream effects of altered SST and PV intrinsic excitability is not straightforward, particularly with the emerging appreciation of both anti- and pro-epileptic roles for these neuron types in seizure initiation and maintenance (Dudok et al., 2022; Magloire et al., 2019). Furthermore, studies using genetic mouse models of DEEs have identified seemingly paradoxical, and sometimes ephemeral, roles of interneurons in disease progression. For instance, in an SCN8A GOF DEE mouse model, increased INaP causes initial SST hyperexcitability followed by depolarization block, and in parallel, chemogenetic activation of WT SST neurons mimics these effects, leading to seizure generation (Wengert et al., 2021). Similarly, in a KCNQ2/3 LOF DEE model, PV-specific Kcnq2/3 deletion causes early PV hyperexcitability that is thought to increase seizure susceptibility via homeostatic potentiation of excitatory transmission (Soh et al., 2018). Lastly, in an Scn1a+/− mouse model of Dravet syndrome, PV neurons are transiently hypoexcitable during development, whereas later they show an increased firing rate, both interictally and at seizure onset, and a decrease in synchrony in the transition to seizure (Favero et al., 2018; Tran et al., 2020). These studies illustrate the challenges in connecting altered interneuron intrinsic excitability with network behavioral outcomes not only because of the contradictory nature of some of these connections but also because of the often transient nature of interneuron phenotypes during disease progression. Thus, future studies should aim to assess neuron-type-specific effects of the YH variant at different developmental time points in both YH-HET mice, with rare seizures, and YH-HOM mice, with frequent seizures, to better understand the contributions of interneuron dysfunction to network pathology and seizure generation in KCNT1 GOF-related epilepsy.

Limitations and conclusions

The in vitro and in silico nature of this study are limitations. Although the cultured VIP, SST, and PV neurons showed characteristic electrophysiological properties, it is unknown how much overlap there is between the in vitro and in vivo populations. For instance, it is possible that our culture conditions select for more mature neurons of each type or preferentially support the survival of subpopulations; thus, we may be assessing KCNT1 GOF effects on a small portion of a given subtype. However, an advantage of the in vitro prep is that the compensatory alterations we observe are not likely consequences of seizure activity, which has been shown to alter interneuron properties in epilepsy models. Furthermore, the in silico neurons we used to model each neuron type were designed to accurately reflect the morphological and electrophysiological properties of each subtype, but they may lack more detailed features of ion channels, such as post-translational modifications and subcellular localizations, that can have important functional effects. Our KCNT1 model conductance is also hampered by an incomplete understanding of the relationship between Na+ influx, membrane voltage, and channel gating in neurons.

Moreover, our K+ current measures using Kcnt1−/−; Kcnt2−/− double knockout neurons clearly showed the presence of an outward VU170-sensitive current across positive potentials, indicating non-specific activity of this small molecule, potentially to the ERG K+ channel (Spitznagel et al., 2020). This off-target effect of VU170 may contribute to the overall increase in outward K+ currents seen in our VU170- vs. TTX-subtracted currents in all neuron types across positive potentials, and it limits the interpretation of the VU170-sensitive KNa current data within this range. Finally, although it is well known that temperature changes can alter neuron physiology, the electrophysiological recordings in this study were performed at room temperature rather than physiological temperature. In this study, we further assessed the effect of temperature (22 vs. 35°C) on rheobase, AP amplitude, and maximal AP firing frequency among WT and YH-HET PV neurons and showed that both groups responded similarly. Previously, we also showed that the effects of the homozygous YH variant on glutamatergic and NFS GABAergic neuron excitability were highly similar between cultured recordings at room temperature (~22°C) and slice recordings at 32°C. Taken together, these data suggest that the reported neurophysiological phenotypes downstream of the YH variant are likely not temperature dependent.

Despite the potential limitations, this study provides three major findings that advance our understanding of the relationship between ion channel function and disease. First, heterozygous KCNT1 expression causes changes in current flow and neuron excitability that are qualitatively similar to homozygous expression, but of a lower magnitude; however, the synaptic activity and connectivity changes are different, which likely leads to the discrepancy in seizure incidence. This finding suggests a non-linear relationship between GOF, at the level of the ion channel current, and disease severity. Second, the same KCNT1 variant can produce opposite effects on neuron excitability in closely related GABAergic neuron subtypes, and these opposite effects are likely due to compensation in one neuron type (PV) that is absent in the other (SST). Previous studies have observed opposite effects on neuronal excitability due to Na+ channel variants, but the underlying mechanism, when explored, was proposed to be intrinsic differences in ion channel expression, not compensation. Third, we observed increased synaptic and gap junction connectivity among SST neurons, demonstrating that the effects of KCNT1 GOF extend to structural alterations as well. The effects of this increased connectivity, especially by gap junctions, on neuronal excitability and network behavior offers an exciting avenue for future research. Finally, it will be critical to determine whether these alterations downstream of KCNT1 GOF potentiate or attenuate network pathology and seizure activity, thus providing a better understanding of disease mechanisms and prompting novel therapeutic design.

Materials and methods

Key resources table
Reagent type (species) or resourceDesignationSource or referenceIdentifiersAdditional information
Genetic reagent (Mus musculus)Kcnt1Y777H knockin mice The Jackson LaboratoryJackson Labs stock: 028830
Genetic reagent (Mus musculus)Sst-IRES-Cre mice The Jackson LaboratoryJackson Labs stock: 013044
Genetic reagent (Mus musculus)Vip-IRES-Cre mice The Jackson LaboratoryJackson Labs stock: 010908
Genetic reagent (Mus musculus)Pvalb-IRES-Cre mice The Jackson LaboratoryJackson Labs stock: 017320
Genetic reagent (Mus musculus) GIN mice The Jackson LaboratoryJackson Labs stock: 003718
Strain, strain background (Mus musculus) C57BL/6J The Jackson LaboratoryJackson Labs stock: 000644
Sequence-based reagent Kcnt1YH_F This paperIDT DNACTAGGGCTG
CAAACACAACA
Sequence-based reagent Kcnt1YH_R This paperIDT DNATCAAGCAGCA
ACACGATAGG
Sequence-based reagent Cre_F This paperIDT DNATCGCGATTATCT
TCTATATCTTCAG
Sequence-based reagent Cre_R This paperIDT DNAGCTCGACCAG
TTTAGTTACCC
Recombinant DNA reagent AAV8-CaMKIIa-GFP UNC Vector Core
Recombinant DNA reagent AAV9-hSyn-DIO-mCherry Addgene50459-AAV9
Chemical compound, drug NBQX disodium salt Tocris1044
Chemical compound, drug Bicuculline methiodide hello bioHB0893
Chemical compound, drug Tetrodotoxin citrate abcamab120055
Software, algorithm pClamp, Clampex 10.3 or 10.5, Clampfit 11.2 Molecular DevicesRRID:SCR_011323
Software, algorithm Axograph X Axograph ScientificRRID:SCR_014284
Software, algorithm Blue Brain Project EPFLRRID:SCR_002994
Software, algorithm NEURON 8.0 The NEURON SimulatorRRID:SCR_005393
Software, algorithm µManager 2.0-βµManagerRRID:SCR_000415
Software, algorithm FijiImageJ, NIHRRID:SCR_002285
Software, algorithm Prism 10 GraphPad PrismRRID: SCR_002798
Software, algorithm SPSS 28.0 IBMRRID:SCR_002865
Antibody Neu-NSynaptic Systems266-0041:500
Antibody Alexa Fluor 647InvitrogenA214501:1000
Other Fluoromount-G Mounting Medium, with DAPIThermo Fisher Scientific00-4959-52See Immunostaining, Imaging, and Quantification section for more information

Mice

Mice were bred, and mouse procedures were conducted, in compliance with the National Institutes of Health (NIH) Guidelines for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee at the University of Vermont (animal protocol numbers: 16-001, 19-034, and X9-022). Mice were maintained in ventilated cages at controlled temperature (22–23°C), humidity ~60%, and 12 hr light: 12 hr dark cycles (lights on at 7:00 AM, off 7:00 PM). Mice had access to regular chow and water, ad libitum. For all experiments, male and female littermates were used for each genotype. The ages of the mice for each experiment are indicated in the following relevant sections.

Mouse lines and strains used for these studies include: Kcnt1Y777H knockin in the C57BL/6NJ (B6NJ) strain (Kcnt1em1(Y777H)Frk; Jackson Labs stock: 028830), Sst-IRES-Cre (Ssttm2.1(cre)Zjh/J; Jackson Labs stock: 013044), Vip-IRES-Cre (Viptm1(cre)Zjh/J; Jackson Labs stock: 010908), Pvalb-IRES-Cre (B6.129P2-Pvalbtm1(cre)Arbr/J; Jackson Lab stock: 017320), Kcnt1−/−; Kcnt2−/− double knockout (a generous gift from Dr. Christopher Lingle at WashU), GIN (FVB-Tg(GadGFP)45704Swn/J; Jackson Lab stock: 003718), and C57BL/6J (Jackson Labs stock: 000664) mice.

Kcnt1Y777H mice were genotyped using PCR amplification primers (Kcnt1 forward primer: 5′-CTAGGGCTGCAAACACAACA-3′; Kcnt1 reverse primer: 5′-TCAAGCAGCAACACGATAGG-3′) with standard thermocycler amplification conditions, and the annealing temperature set at 58°C. Following amplification, a restriction cut was performed with the enzyme NlaIII to distinguish mutant (127 and 44 bp products after cut) from WT alleles (171 bp product). Progeny of the Kcnt1Y777H mice crossed to each Cre mouse line were genotyped for the presence of a Cre transgene using a forward primer (5′-TCGCGATTATCTTCTATATCTTCAG-3′) and reverse primer (5′-GCTCGACCAGTTTAGTTACCC-3′), resulting in a 455-bp product.

Primary astrocyte feeder layer culture

Request a detailed protocol

Astrocyte feeder layers were generated to support the growth and maintenance of primary neurons. Briefly, cortices were dissected from P0 to P1 WT C57BL/6J mice (Jackson Labs stock: 000664) of either sex. The cortices were incubated in 0.05% trypsin–EDTA (Gibco) for 15 min at 37°C in a Thermomixer (Eppendorf) with gentle agitation (800 rpm). Then, the cortices were mechanically dissociated with a 1-ml pipette tip, and the cells were plated into T-75 flasks containing filter-sterilized astrocyte media [Dulbecco’s Modified Eagle Medium (DMEM) supplemented with glutamine (Gibco), 10% fetal bovine serum (GE Healthcare), 1× MITO +Serum Extender (Corning), and 0.2× penicillin/streptomycin (Gibco)]. After the astrocytes reached confluency, they were washed with phosphate-buffered saline (PBS; Gibco) and incubated for 5 min in 0.05% trypsin–EDTA at 37°C, washed, and then resuspended in astrocyte media. Astrocytes were added to 6-well plates containing 25 mm coverslips precoated with coating mixture [0.7 mg/ml collagen I (Corning) and 0.1 mg/ml poly-d-lysine (Sigma) in 10 mM acetic acid].

Primary cortical neuron culture

Request a detailed protocol

For the primary neuron culture, the dorsomedial cortices from P0 to P1 WT and Kcnt1m/+ mice of both sexes were dissected in cold Hank’s Balanced Salt Solution (HBSS; Gibco). The tissue was then digested with papain (Worthington) for 60–75 min and treated with inactivating solution (Worthington) for 10 min, both while shaking at 800 rpm at 37°C in a Thermomixer. The cells were then mechanically dissociated and counted. The dissociated cells were added at 200,000 cells/well to 6-well plates containing astrocyte-coated coverslips in filter-sterilized NBA plus [Neurobasal-A medium (Gibco) supplemented with 1× Glutamax (Gibco), 1× B27 (Invitrogen), and 0.2× penicillin/streptomycin (Gibco)]. After plating (12–24 hr), approximately 4 × 1010 genome copies (GC) of AAV8-CaMKIIa-GFP (UNC Vector Core) were added to each well. For experiments to assess KCNT1 effects on GABAergic subtypes, approximately 4 × 1010 GC of AAV9-hSyn-DIO-mCherry (Addgene) were also added to each well to mark Cre-expressing neurons. Every 3–4 days, 20–40% of the media was replaced with fresh NBA plus.

Electrophysiology

Request a detailed protocol

Whole-cell recordings were performed with patch-clamp amplifiers (MultiClamp 700B; Molecular Devices) under the control of Clampex 10.3 or 10.5 (Molecular Devices, pClamp, RRID:SCR_011323). Data were acquired at 20 kHz and low-pass filtered at 6 kHz. The series resistance was compensated at 70%, and only cells with series resistances maintained at less than 15 MΩ were analyzed. Patch electrodes were pulled from 1.5 mm o.d. thin-walled glass capillaries (Sutter Instruments) in five stages on a micropipette puller (model P-97; Sutter Instruments). Internal solution contained the following: 136 mM K-gluconate, 17.8 mM HEPES, 1 mM EGTA, 0.6 mM MgCl2, 4 mM ATP, 0.3 mM GTP, 12 mM creatine phosphate, and 50 U/ml phosphocreatine kinase. Alternatively, internal solution contained: 136 mm KCl, 17.8 mm HEPES, 1 mm EGTA, 0.6 mm MgCl2, 4 mm ATP, 0.3 mm GTP, 12 mm creatine phosphate, and 50 U/ml phosphocreatine kinase. The pipette resistance was between 2 and 4 MΩ. Standard extracellular solution contained the following (in mM): 140 NaCl, 2.4 KCl, 10 HEPES, 10 glucose, 4 MgCl2, and 2 CaCl2 (pH 7.3, 305 mOsm). All experiments were performed at room temperature (22–23°C), with the exception of the current-clamp experiments to compare the effects of temperature on neuronal physiology (Figure 4—figure supplement 3). For these recordings, all current-clamp parameters were measured first at room temperature, then the temperature of the external solution was heated to 35°C using a ThermoClamp Inline Heater (ThermoClamp-3; AutoMate Scientific), and the measurements were repeated. Whole-cell recordings were performed on cortical neurons from control and mutant groups in parallel on the same day (day 13–17 in vitro). All experiments were performed by two independent investigators blinded to the genotypes.

For current-clamp experiments, the intrinsic electrophysiological properties of neurons were tested by injecting 500 ms square current pulses incrementing in 20 pA steps, starting at −100 pA. Resting membrane potential (Vm) was calculated from a 50-ms average before current injection. The membrane time constant (τ) was calculated from an exponential fit of current stimulus offset. Input resistance (RIn) was calculated from the steady state of the voltage responses to the hyperpolarizing current steps. Membrane capacitance was calculated by dividing the time constant by the input resistance. APs were evoked with 0.5 s, 20 pA depolarizing current steps. Rheobase was defined as the minimum current required to evoke an AP during the 500 ms of sustained somatic current injections. AP threshold was defined as the membrane potential at the inflection point of the rising phase of the AP. AP amplitude was defined as the difference in membrane potential between the AP peak and threshold, and the AHP was the difference between the AP threshold and the lowest Vm value within 50ms. The AP half-width was defined as the width of the AP at half-maximal amplitude. To obtain the neuron’s maximum firing frequency, depolarizing currents in 20 pA steps were injected until the number of APs per stimulus reached a plateau phase. The membrane potential values were not corrected for the liquid junction potential. GABAergic neurons were classified as FS if their maximum mean firing rate reached above 60 Hz and their AP half-widths increased by less than 25% during 1 s of sustained firing (Avermann et al., 2012; Casale et al., 2015). All others were considered NFS.

For voltage-clamp experiments to measure synaptic currents, neurons were held at −70 mV, except for evoked IPSC measurements, for which neurons were held at 0 mV. AP-evoked EPSCs were triggered by a 2-ms somatic depolarization to 0 mV. The shape of the evoked response, the reversal potential and the effect of receptor antagonists [10 μM NBQX (Tocris Bioscience) or 20 μM bicuculline (BIC, hello bio)] were analyzed to verify the glutamatergic or GABAergic identities of the currents. Neurons were stimulated at 0.1 Hz in standard external solution to measure basal-evoked synaptic responses. Electrophysiology data were analyzed offline with AxoGraph X software (AxoGraph Scientific, RRID:SCR_014284). Spontaneous synaptic potentials were recorded in control solution with either NBQX or BIC to isolate EPSCs or IPSCs, respectively. Data were filtered at 1 kHz and analyzed using template-based miniature event detection algorithms implemented in the AxoGraph X. The threshold for detection was set at three times the baseline SD from a template of 0.5 ms rise time and 3 ms decay. The E/I ratio was calculated as the product of the sEPSC frequency and charge over the sum of the sEPSC frequency and charge and the product of the sIPSC frequency and charge.

KNa and KCNT1 current measurements

Request a detailed protocol

For voltage-clamp experiments to measure the sodium-activated K+ current or KCNT1-mediated current, neurons were held at −70 mV and given 1 s voltage pulses in 10 mV steps over a range of −80 to +50 mV. Recordings were obtained for each cell in standard extracellular solution or extracellular solution containing 0.5 µM TTX or 10 µM VU170. TTX or VU170 was applied directly on the recorded neuron with a custom-built fast flow perfusion system capable of complete solution exchange in less than 1 s to minimize the time interval between control and drug recordings and current rundown. Current traces from the TTX or VU170 solution were subtracted from the current traces obtained from the standard solution. The difference current over the 100ms at the end of the voltage pulse was considered the steady-state KNa current. The same protocol was used for outside-out patch experiments.

INaP current measurements

Request a detailed protocol

For voltage-clamp experiments to measure the persistent Na+ current, neurons were held at −80 mV and given a 5-s voltage ramp at 20 mV/s. The ramp was repeated every 10 s. Recordings were obtained for each cell in standard extracellular solution or extracellular solution containing 0.5 µM TTX. TTX was applied directly on the recorded neuron with a custom-built fast flow perfusion system capable of complete solution exchange in less than 1 s to minimize the time interval between control and TTX recordings. The first current trace after TTX application was subtracted from the averaged current traces obtained from the standard solution. At this time point, the effect of TTX on the Na+-activated K+ current is minimal, while the persistent Na+ current is maximally inhibited. This allowed us to isolate the persistent Na+ current from KNa and obtain a more accurate estimate of changes in INaP.

Neuron modeling

Request a detailed protocol

Model neurons (~10 per class) representing excitatory (Pyramidal Cell, PC), SST (Martinotti Cell, MC), PV (Large Basket Cell, LBC), and VIP neurons (Bipolar Cell, BP) were downloaded from the EPFL/Blue Brain project (https://bbp.epfl.ch/nmc-portal/downloads.html), and implemented in the NEURON environment. Because no KCNT1-like conductance was present in the original models, a Hodgkin-Huxley KCNT1 model conductance was created with both Na+- and voltage-dependent gates and inserted into the dendritic, somatic, and axonal compartments of model neurons (0.03 S/cm2). The Na+ dependence was modeled after Bischoff et al. (EC50 = 40 mM, slope 3.5), and the voltage dependence was modeled after our own experimental data (Figure 5), corrected to account for the calculated liquid junction potential in the experimental data. To verify that this approach reproduced experimental data, voltage step protocols were run in NEURON with 10 and 0 mM internal Na+. ‘KNa’ currents were obtained by subtraction, and the amplitude and kinetics of the resulting currents were verified to be similar to experimental values. To model the effects of KCNT1 GOF, the EC50 for Na+ was decreased to either 35 or 30 mM, because the Y796H variant was previously shown to increase the Na+ sensitivity of the channel. These changes resulted in moderate increases in the current above WT levels (Figure 6B), consistent with the experimental data (Figures 4 and 5). Modeling data were generated by running current clamp protocols in NEURON for each of the model neurons and analyzed in the same way as experimental data. For modeling the increase in INaP, the control INaP conductance was set to 0.001 times the conductance of the transient Na+ current in each compartment. This produced INaP currents approximately 1% of the peak of the transient Na+ current. KCNT1 GOF was modeled by decreasing the Na+ EC50 to 30 mM and the INaP increase was modeled by increasing its conductance twofold, in accordance with experimental data.

Immunostaining, imaging, and quantification

Request a detailed protocol

For live imaging of GABAergic subtypes in vitro, cortical neurons isolated and cultured from VIP-Cre, SST-Cre, and PV-Cre pups, were infected with AAV-CamKIIa-GFP and AAV-hSyn-DIO-mCherry viruses at DIV 1 to mark glutamatergic and Cre-expressing, GABAergic neurons, respectively. Images were captured from live cultures at DIV 14 (VIP-Cre and SST-Cre) or DIV 16 (PV-Cre) using an inverted Olympus IX73 epifluorescent microscope with an Olympus PlanFluor ×10 objective lens and an Andor Zyla sCMOS 4.2 camera controlled by μManager 2.0-β software (Edelstein et al., 2014). The same acquisition parameters were used for each image and each group.

For soma size measurements, DIV 16 cultured SST-Cre neurons on coverslips were washed three times with prewarmed PBS, fixed with 4% paraformaldehyde in PBS for 30 min at room temperature, and then washed again three times with PBS. The fixed neurons were then incubated in blocking buffer (10% normal goat serum and 0.1% Triton-100 in 1× PBS) for 1 hr at room temperature, followed by incubation with a Neu-N primary antibody (Synaptic Systems 266-004) diluted in blocking buffer (1:500) overnight at 4°C. The next day, the neurons were washed three times with PBS for 10–15 min, incubated with goat anti-guinea pig, Alexa Fluor 647 secondary antibody (Invitrogen A21450) in blocking buffer (1:1000) for 1 hr at room temperature, and washed again three times with PBS for 10–15 min. The coverslips were then flipped and mounted on glass slides using Fluoromount G with DAPI (Thermo Fisher Scientific). Images (1024 × 1024 pixels) of Neu-N to mark all neurons, CamKIIa-GFP to mark glutamatergic neurons, and hSyn-DIO-mCherry to mark Cre-expressing neurons, were obtained using a DeltaVision Restoration Microscopy System (Applied Precision/GE Life Sciences) with an inverted Olympus IX70 microscope with a ×20 oil objective, SoftWoRx software, and a CoolSNAP-HQ charge-coupled device digital camera (Photometrics). Image exposure times and settings were kept the same between groups in a culture and were optimized to ensure that there were no saturated pixels. To analyze soma size, regions of interest were drawn around cell bodies using the mCherry channel with Fiji software (Schindelin et al., 2012), and then the cell body areas were measured for each mCherry+ neuron imaged.

Mouse cortex slice preparation

Request a detailed protocol

Cortical slices were prepared from P21 to P30 WT and Kcnt1Y777H heterozygous pups of both sexes that were the progeny of Kcnt1Y777H heterozygous mice crossed to homozygous GIN mice (Jackson Labs stock: 003718), which express GFP in a subset of SST-positive neurons (Ma et al., 2006; Oliva et al., 2000), following a modified protocol (Ting et al., 2014). Briefly, mice were deeply anesthetized with isoflurane and transcardially perfused with 25–30 ml of ice-cold N-methyl-D-glucamine (NMDG)-based artificial cerbrospinal fluid (aCSF) (in mM: 93 NMDG, 2.5 KCl, 1.2 NaH2PO4, 30 NaHCO3, 20 HEPES, 25 d-glucose, 5 Na-ascorbate, 2 thiourea, 3 Na-pyruvate, 12 N-acetyl-l-cysteine, 10 MgSO4, 0.5 CaCl2, with pH adjusted to 7.3–7.4 with 10 N HCl) that was saturated with carbogen 95% O2, 5% CO2 (pH 7.3–7.4). The mice were rapidly decapitated, and the heads were submerged in ice-cold NMDG aCSF bubbled with carbogen. After extraction from the skull, the cortex was blocked and 250 μm coronal sections were cut with a vibrating microslicer (Leica VT100S, Leica Biosystems) while submerged in the same solution. Slices were first moved to NMDG aCSF at 32–34°C for a short-term recovery (≤15 min) before being transferred into HEPES-based holding aCSF (in mM: 92 NaCl, 2.5 KCl, 1.2 NaH2PO4, 30 NaHCO3, 20 HEPES, 25 d-glucose, 5 Na-ascorbate, 2 thiourea, 3 Na-pyruvate, 12 N-acetyl-l-cysteine, 2 MgSO4, 2 CaCl2, bubbled with carbogen, with pH adjusted to 7.3–7.4 with KOH or HCl as necessary). The slices were held in this solution until use.

Ex vivo slice electrophysiology

Request a detailed protocol

For recording, the cortical slices were placed in a chamber mounted on a fluorescence microscope (Zeiss Axio Examiner.D1) and perfused with normal Ringer’s solution containing (in mM): 130 NaCl, 3 KCl, 2 MgCl2, 2 CaCl2, 1.25 NaH2PO4, 26 NaHCO3, and 10 d-glucose, bubbled with carbogen. Patch electrodes were pulled from 1.5 mm o.d. thin-walled glass capillaries (Garner Glass Company) in two stages on a micropipette puller (model P-1000; Sutter Instruments). Electrophysiological recordings were obtained from GFP-labeled neurons in layer 2/3 of either motor or somatosensory cortex using pClamp, an MultiClamp 700B amplifier, and a Digidata 1440A analog-to-digital converter (Molecular Devices). Data were acquired at 20 kHz and low-pass filtered at 10 kHz. Internal solution contained the following (in mM): 17.5 KCl, 112.5 K-gluconate, 1.5 NaCl, 5 Na2-phosphocreatine, 1 MgCl2, 10 HEPES, 0.2 EGTA, 3 Mg-ATP, 0.3 GTP-Tris (pH 7.2, with KOH). The pipette resistance was between 3 and 5 MΩ. All experiments were performed at room temperature (22–23°C).

The intrinsic electrophysiological properties of neurons were tested using current-clamp recording under whole-cell configuration by injecting 1 s square current pulses in 5 pA steps, starting at −30 pA. All recordings were saved in the computer for off-line analysis using Clampfit 11.2 or Axograph X software. The membrane time constant (τ) was calculated from an exponential fit of current stimulus offset. Input resistance (Rin) was calculated from the steady state of the voltage responses to the hyperpolarizing current steps. Membrane capacitance was calculated by dividing the time constant by the input resistance. AP frequency was counted on each depolarizing current step and plotted as a function of injection current. Rheobase was defined as the minimum current required to evoke an AP during the 1 s of sustained somatic current injections. AP threshold was defined as the membrane potential at the inflection point of the rising phase of the AP, and the AHP was the difference between the AP threshold and the lowest Vm value within 50 ms. The membrane potential values were not corrected for the liquid junction potential.

Data presentation and statistical analysis

Request a detailed protocol

Prism 10 (GraphPad Prism, RRID:SCR_002798) was used to create all graphs. To test for statistical significance for all whole-cell electrophysiology experiments, we used generalized linear mixed models in SPSS [28.0 Chicago, III (IBM, RRID:SCR_002865)], which allows for within-subject correlations and the specification of the most appropriate distribution for the data. Because neurons and animals from the same culture or animal are not independent measurements, culture or litter was used as the subject variable, and animals, neurons, and voltage steps were considered within-subject measurements. All data distributions were assessed with the Shapiro–Wilk test. Datasets that were significantly different from the normal distribution (p < 0.05) were fit with models using the gamma distribution and a log link function, except for synaptic connection probability, which was fit with the binomial distribution and probit link. Normal datasets were fit with models using a linear distribution and identity link. We used the model-based estimator for the covariance matrix and goodness of fit was determined using the corrected quasi likelihood under independence model criterion and by the visual assessment of residuals. All values reported in the text, figures, and tables are estimated marginal means ± standard error, except where noted.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files; source data files have been provided for all figures.

References

Article and author information

Author details

  1. Amy N Shore

    1. Fralin Biomedical Research Institute at Virginia Tech Carilion, Center for Neurobiology Research, Roanoke, United States
    2. Department of Neurological Sciences, University of Vermont, Burlington, United States
    Contribution
    Conceptualization, Data curation, Formal analysis, Supervision, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing
    Competing interests
    No competing interests declared
  2. Keyong Li

    Fralin Biomedical Research Institute at Virginia Tech Carilion, Center for Neurobiology Research, Roanoke, United States
    Contribution
    Formal analysis, Investigation
    Competing interests
    No competing interests declared
  3. Mona Safari

    1. Fralin Biomedical Research Institute at Virginia Tech Carilion, Center for Neurobiology Research, Roanoke, United States
    2. Translational Biology, Medicine, and Health Graduate Program, Fralin Biomedical Research Institute at Virginia Tech Carilion, Roanoke, United States
    Contribution
    Formal analysis, Investigation
    Competing interests
    No competing interests declared
  4. Alshaima'a M Qunies

    1. Department of Pharmaceutical Sciences, UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, United States
    2. School of Biomedical Sciences, University of North Texas Health Science Center, Fort Worth, United States
    Contribution
    Resources
    Competing interests
    No competing interests declared
  5. Brittany D Spitznagel

    1. Department of Pharmacology, Vanderbilt University, Nashville, United States
    2. Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, United States
    3. Department of Chemistry, Vanderbilt University, Nashville, United States
    Contribution
    Resources
    Competing interests
    No competing interests declared
  6. C David Weaver

    1. Department of Pharmacology, Vanderbilt University, Nashville, United States
    2. Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, United States
    3. Department of Chemistry, Vanderbilt University, Nashville, United States
    Contribution
    Resources
    Competing interests
    No competing interests declared
  7. Kyle Emmitte

    Department of Pharmaceutical Sciences, UNT System College of Pharmacy, University of North Texas Health Science Center, Fort Worth, United States
    Contribution
    Resources
    Competing interests
    No competing interests declared
  8. Wayne Frankel

    1. Institute for Genomic Medicine, Columbia University, New York, United States
    2. Department of Neurology, Columbia University, New York, United States
    Contribution
    Resources
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2241-5314
  9. Matthew C Weston

    1. Fralin Biomedical Research Institute at Virginia Tech Carilion, Center for Neurobiology Research, Roanoke, United States
    2. Department of Neurological Sciences, University of Vermont, Burlington, United States
    3. Translational Biology, Medicine, and Health Graduate Program, Fralin Biomedical Research Institute at Virginia Tech Carilion, Roanoke, United States
    4. School of Neuroscience, Virginia Tech, Blacksburg, United States
    Contribution
    Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Writing – original draft, Project administration, Writing – review and editing
    For correspondence
    mcweston7c@vt.edu
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5558-7070

Funding

NIH/NINDS (R01NS130042)

  • Matthew C Weston

NIH/NINDS (R01NS031348)

  • Wayne Frankel

NIH/NINDS (R33NS109521)

  • C David Weaver
  • Kyle Emmitte

NIH/NINDS (U54OD020351)

  • Wayne Frankel

NIH/NINDS (R01 NS110945)

  • Matthew C Weston

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Acknowledgements

This work was supported by NIH/NINDS grants R01NS110945 (MCW), R01NS130042 (MCW), R01NS031348 (WNF), R33NS109521 (CDW and KAE), and U54OD020351 (WNF, The Jackson Laboratory Center for Precision Genetics). The authors would like to acknowledge the support of the Microscopy Imaging Center (RRID# SCR_018821) and the Cellular & Molecular Core at the University of Vermont. The authors would like to thank Dr. Christopher Lingle of Washington University of St. Louis for providing the Kcnt1−/−; Kcnt2−/− double knockout mice to test the specificity of the VU170 KCNT1 inhibitor.

Ethics

This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All surgery was performed under isofluorane anesthesia, and every effort was made to minimize suffering. All mice were bred, and procedures were conducted at the Fralin Biomedical Research Institute at VTC, or at the University of Vermont. Each institution is fully accredited by the Association for Assessment and Accreditation of Laboratory Animal Care, and all protocols were approved by their respective Institutional Animal Care and Use Committees. All experiments were performed in accordance with respective state and federal Animal Welfare Acts and the policies of the Public Health Service. The animal protocol numbers for Virginia Tech were 22-198 and 22-130, and the University of Vermont were 16-001 and 19-034.

Version history

  1. Preprint posted:
  2. Sent for peer review:
  3. Reviewed Preprint version 1:
  4. Reviewed Preprint version 2:
  5. Reviewed Preprint version 3:
  6. Version of Record published:

Cite all versions

You can cite all versions using the DOI https://doi.org/10.7554/eLife.92915. This DOI represents all versions, and will always resolve to the latest one.

Copyright

© 2024, Shore et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 850
    views
  • 64
    downloads
  • 0
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Amy N Shore
  2. Keyong Li
  3. Mona Safari
  4. Alshaima'a M Qunies
  5. Brittany D Spitznagel
  6. C David Weaver
  7. Kyle Emmitte
  8. Wayne Frankel
  9. Matthew C Weston
(2024)
Heterozygous expression of a Kcnt1 gain-of-function variant has differential effects on somatostatin- and parvalbumin-expressing cortical GABAergic neurons
eLife 13:RP92915.
https://doi.org/10.7554/eLife.92915.4

Share this article

https://doi.org/10.7554/eLife.92915

Further reading

    1. Neuroscience
    Yujiro Umezaki, Sergio Hidalgo ... Fumika Hamada
    Research Article

    Hungry animals consistently show a desire to obtain food. Even a brief sensory detection of food can trigger bursts of physiological and behavioral changes. However, the underlying mechanisms by which the sensation of food triggers the acute behavioral response remain elusive. We have previously shown in Drosophila that hunger drives a preference for low temperature. Because Drosophila is a small ectotherm, a preference for low temperature implies a low body temperature and a low metabolic rate. Here, we show that taste-sensing triggers a switch from a low to a high temperature preference in hungry flies. We show that taste stimulation by artificial sweeteners or optogenetics triggers an acute warm preference, but is not sufficient to reach the fed state. Instead, nutrient intake is required to reach the fed state. The data suggest that starvation recovery is controlled by two components: taste-evoked and nutrient-induced warm preferences, and that taste and nutrient quality play distinct roles in starvation recovery. Animals are motivated to eat based on time of day or hunger. We found that clock genes and hunger signals profoundly control the taste-evoked warm preferences. Thus, our data suggest that the taste-evoked response is one of the critical layers of regulatory mechanisms representing internal energy homeostasis and metabolism.

    1. Medicine
    2. Neuroscience
    Sophie Leclercq, Hany Ahmed ... Nathalie Delzenne
    Research Article

    Background:

    Alcohol use disorder (AUD) is a global health problem with limited therapeutic options. The biochemical mechanisms that lead to this disorder are not yet fully understood, and in this respect, metabolomics represents a promising approach to decipher metabolic events related to AUD. The plasma metabolome contains a plethora of bioactive molecules that reflects the functional changes in host metabolism but also the impact of the gut microbiome and nutritional habits.

    Methods:

    In this study, we investigated the impact of severe AUD (sAUD), and of a 3-week period of alcohol abstinence, on the blood metabolome (non-targeted LC-MS metabolomics analysis) in 96 sAUD patients hospitalized for alcohol withdrawal.

    Results:

    We found that the plasma levels of different lipids ((lyso)phosphatidylcholines, long-chain fatty acids), short-chain fatty acids (i.e. 3-hydroxyvaleric acid) and bile acids were altered in sAUD patients. In addition, several microbial metabolites, including indole-3-propionic acid, p-cresol sulfate, hippuric acid, pyrocatechol sulfate, and metabolites belonging to xanthine class (paraxanthine, theobromine and theophylline) were sensitive to alcohol exposure and alcohol withdrawal. 3-Hydroxyvaleric acid, caffeine metabolites (theobromine, paraxanthine, and theophylline) and microbial metabolites (hippuric acid and pyrocatechol sulfate) were correlated with anxiety, depression and alcohol craving. Metabolomics analysis in postmortem samples of frontal cortex and cerebrospinal fluid of those consuming a high level of alcohol revealed that those metabolites can be found also in brain tissue.

    Conclusions:

    Our data allow the identification of neuroactive metabolites, from interactions between food components and microbiota, which may represent new targets arising in the management of neuropsychiatric diseases such as sAUD.

    Funding:

    Gut2Behave project was initiated from ERA-NET NEURON network (Joint Transnational Call 2019) and was financed by Academy of Finland, French National Research Agency (ANR-19-NEUR-0003-03) and the Fonds de la Recherche Scientifique (FRS-FNRS; PINT-MULTI R.8013.19, Belgium). Metabolomics analysis of the TSDS samples was supported by grant from the Finnish Foundation for Alcohol Studies.